Frequencies for first 10,000 rows of pt variable in reac2007q4 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 12 0.12 0.12 ABDOMINAL DISCOMFORT | 3 0.03 0.15 ABDOMINAL DISTENSION | 12 0.12 0.27 ABDOMINAL HERNIA | 1 0.01 0.28 ABDOMINAL INFECTION | 1 0.01 0.29 ABDOMINAL MASS | 3 0.03 0.32 ABDOMINAL NEOPLASM | 1 0.01 0.33 ABDOMINAL PAIN | 26 0.26 0.59 ABDOMINAL PAIN LOWER | 1 0.01 0.60 ABDOMINAL PAIN UPPER | 30 0.30 0.90 ABDOMINAL RIGIDITY | 2 0.02 0.92 ABDOMINAL WALL ANOMALY | 1 0.01 0.93 ABNORMAL BEHAVIOUR | 10 0.10 1.03 ABNORMAL DREAMS | 16 0.16 1.19 ABNORMAL FAECES | 1 0.01 1.20 ABNORMAL PALMAR/PLANTAR CREASES | 1 0.01 1.21 ABORTION INDUCED | 1 0.01 1.22 ABORTION OF ECTOPIC PREGNANCY | 1 0.01 1.23 ABORTION SPONTANEOUS | 12 0.12 1.35 ABSCESS DRAINAGE | 1 0.01 1.36 ACCIDENT | 2 0.02 1.38 ACCIDENTAL DEATH | 1 0.01 1.39 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 1.40 ACCIDENTAL EXPOSURE | 3 0.03 1.43 ACCIDENTAL OVERDOSE | 13 0.13 1.56 ACCOMMODATION DISORDER | 1 0.01 1.57 ACIDOSIS | 1 0.01 1.58 ACNE | 8 0.08 1.66 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 1 0.01 1.67 ACTIVITIES OF DAILY LIVING IMPAIRED | 10 0.10 1.77 ACUTE ABDOMEN | 1 0.01 1.78 ACUTE CORONARY SYNDROME | 1 0.01 1.79 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 1.80 ACUTE GRAFT VERSUS HOST DISEASE | 1 0.01 1.81 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 2 0.02 1.83 ACUTE GRAFT VERSUS HOST DISEASE IN LI.. | 2 0.02 1.85 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 2 0.02 1.87 ACUTE HEPATIC FAILURE | 2 0.02 1.89 ACUTE LEUKAEMIA | 1 0.01 1.90 ACUTE MYELOID LEUKAEMIA | 2 0.02 1.92 ACUTE MYELOID LEUKAEMIA RECURRENT | 1 0.01 1.93 ACUTE MYOCARDIAL INFARCTION | 3 0.03 1.96 ACUTE RESPIRATORY DISTRESS SYNDROME | 9 0.09 2.05 ACUTE RESPIRATORY FAILURE | 1 0.01 2.06 ADENOVIRUS INFECTION | 1 0.01 2.07 ADRENAL CARCINOMA | 1 0.01 2.08 ADRENAL INSUFFICIENCY | 2 0.02 2.10 ADRENAL MASS | 1 0.01 2.11 ADRENAL SUPPRESSION | 1 0.01 2.12 ADVERSE DRUG REACTION | 6 0.06 2.18 ADVERSE EVENT | 11 0.11 2.29 AFFECT LABILITY | 4 0.04 2.33 AGEUSIA | 3 0.03 2.36 AGGRESSION | 22 0.22 2.58 AGITATION | 12 0.12 2.70 AGRANULOCYTOSIS | 4 0.04 2.74 AIDS ENCEPHALOPATHY | 1 0.01 2.75 AKATHISIA | 3 0.03 2.78 ALANINE AMINOTRANSFERASE DECREASED | 2 0.02 2.80 ALANINE AMINOTRANSFERASE INCREASED | 15 0.15 2.95 ALICE IN WONDERLAND SYNDROME | 1 0.01 2.96 ALKALOSIS HYPOKALAEMIC | 1 0.01 2.97 ALLERGIC GRANULOMATOUS ANGIITIS | 3 0.03 3.00 ALLERGY TO CHEMICALS | 1 0.01 3.01 ALOPECIA | 50 0.50 3.51 ALTERED STATE OF CONSCIOUSNESS | 12 0.12 3.63 ALVEOLAR OSTEITIS | 1 0.01 3.64 AMAUROSIS | 1 0.01 3.65 AMENORRHOEA | 1 0.01 3.66 AMMONIA INCREASED | 1 0.01 3.67 AMNESIA | 33 0.33 4.00 AMOEBIASIS | 1 0.01 4.01 AMOEBIC DYSENTERY | 1 0.01 4.02 AMYLOIDOSIS | 1 0.01 4.03 ANAEMIA | 47 0.47 4.50 ANAEMIA MACROCYTIC | 2 0.02 4.52 ANAEMIA MEGALOBLASTIC | 1 0.01 4.53 ANAESTHETIC COMPLICATION | 1 0.01 4.54 ANAL ATRESIA | 1 0.01 4.55 ANAL CANCER | 2 0.02 4.57 ANAL DISCOMFORT | 1 0.01 4.58 ANAL FISSURE | 1 0.01 4.59 ANAL HAEMORRHAGE | 2 0.02 4.61 ANAPHYLACTIC REACTION | 8 0.08 4.69 ANAPHYLACTIC SHOCK | 9 0.09 4.78 ANAPHYLACTOID SHOCK | 2 0.02 4.80 ANDROGENS DECREASED | 1 0.01 4.81 ANGER | 13 0.13 4.94 ANGINA PECTORIS | 5 0.05 4.99 ANGINA UNSTABLE | 3 0.03 5.02 ANGIOCENTRIC LYMPHOMA | 1 0.01 5.03 ANGIOEDEMA | 10 0.10 5.13 ANGIOLIPOMA | 1 0.01 5.14 ANGIOPATHY | 1 0.01 5.15 ANGIOPLASTY | 2 0.02 5.17 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.18 ANHEDONIA | 1 0.01 5.19 ANISOCYTOSIS | 1 0.01 5.20 ANKLE FRACTURE | 3 0.03 5.23 ANKYLOGLOSSIA CONGENITAL | 1 0.01 5.24 ANKYLOSING SPONDYLITIS | 1 0.01 5.25 ANOREXIA | 23 0.23 5.48 ANOSMIA | 1 0.01 5.49 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 5.50 ANTIBODY TEST POSITIVE | 1 0.01 5.51 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 5.52 ANTICONVULSANT DRUG LEVEL DECREASED | 2 0.02 5.54 ANTICONVULSANT DRUG LEVEL INCREASED | 2 0.02 5.56 ANTINUCLEAR ANTIBODY POSITIVE | 2 0.02 5.58 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAP.. | 1 0.01 5.59 ANTISOCIAL BEHAVIOUR | 1 0.01 5.60 ANURIA | 2 0.02 5.62 ANXIETY | 48 0.48 6.10 AORTIC ANEURYSM RUPTURE | 1 0.01 6.11 AORTIC STENOSIS | 1 0.01 6.12 AORTIC THROMBOSIS | 1 0.01 6.13 AORTIC VALVE INCOMPETENCE | 2 0.02 6.15 APGAR SCORE LOW | 1 0.01 6.16 APHAGIA | 1 0.01 6.17 APHASIA | 4 0.04 6.21 APHONIA | 2 0.02 6.23 APHTHOUS STOMATITIS | 2 0.02 6.25 APLASIA | 3 0.03 6.28 APLASIA PURE RED CELL | 4 0.04 6.32 APLASTIC ANAEMIA | 2 0.02 6.34 APNOEA | 4 0.04 6.38 APNOEIC ATTACK | 1 0.01 6.39 APPENDICECTOMY | 1 0.01 6.40 APPENDICITIS | 2 0.02 6.42 APPLICATION SITE ANAESTHESIA | 1 0.01 6.43 APPLICATION SITE BURN | 1 0.01 6.44 APPLICATION SITE DISCHARGE | 1 0.01 6.45 APPLICATION SITE DISCOLOURATION | 1 0.01 6.46 APPLICATION SITE ERYTHEMA | 3 0.03 6.49 APPLICATION SITE IRRITATION | 2 0.02 6.51 APPLICATION SITE NECROSIS | 1 0.01 6.52 APPLICATION SITE PAIN | 2 0.02 6.54 APPLICATION SITE PRURITUS | 2 0.02 6.56 APPLICATION SITE RASH | 1 0.01 6.57 APTYALISM | 1 0.01 6.58 ARACHNOID CYST | 1 0.01 6.59 AREFLEXIA | 2 0.02 6.61 ARRHYTHMIA | 18 0.18 6.79 ARTERIAL DISORDER | 1 0.01 6.80 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 6.81 ARTERIAL THROMBOSIS | 2 0.02 6.83 ARTERIOSCLEROSIS | 3 0.03 6.86 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 6.87 ARTERIOSCLEROSIS OBLITERANS | 1 0.01 6.88 ARTERY DISSECTION | 1 0.01 6.89 ARTHRALGIA | 165 1.65 8.54 ARTHRITIS | 26 0.26 8.80 ARTHRITIS INFECTIVE | 2 0.02 8.82 ARTHROPATHY | 9 0.09 8.91 ARTHROPOD BITE | 2 0.02 8.93 ASCITES | 7 0.07 9.00 ASCITES INFECTION | 1 0.01 9.01 ASPARTATE AMINOTRANSFERASE INCREASED | 15 0.15 9.16 ASPERGILLOSIS | 1 0.01 9.17 ASPHYXIA | 1 0.01 9.18 ASPIRATION | 1 0.01 9.19 ASTEATOSIS | 1 0.01 9.20 ASTERIXIS | 1 0.01 9.21 ASTHENIA | 71 0.71 9.92 ASTHENOPIA | 1 0.01 9.93 ASTHMA | 15 0.15 10.08 ASTHMATIC CRISIS | 1 0.01 10.09 ATELECTASIS | 3 0.03 10.12 ATRIAL FIBRILLATION | 12 0.12 10.24 ATRIAL FLUTTER | 1 0.01 10.25 ATRIAL SEPTAL DEFECT | 6 0.06 10.31 ATRIAL THROMBOSIS | 1 0.01 10.32 ATRIOVENTRICULAR BLOCK | 2 0.02 10.34 ATRIOVENTRICULAR BLOCK COMPLETE | 1 0.01 10.35 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 10.36 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 10.37 ATROPHIC VULVOVAGINITIS | 1 0.01 10.38 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 1 0.01 10.39 ATYPICAL MYCOBACTERIAL INFECTION | 2 0.02 10.41 AURICULAR SWELLING | 1 0.01 10.42 AUTOIMMUNE THROMBOCYTOPENIA | 1 0.01 10.43 AUTOIMMUNE THYROIDITIS | 1 0.01 10.44 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 10.45 AUTOTRANSFUSION | 1 0.01 10.46 AXILLARY MASS | 1 0.01 10.47 AXILLARY PAIN | 1 0.01 10.48 B-CELL LYMPHOMA | 1 0.01 10.49 BACK DISORDER | 1 0.01 10.50 BACK PAIN | 37 0.37 10.87 BACTERAEMIA | 3 0.03 10.90 BACTERIA BLOOD IDENTIFIED | 1 0.01 10.91 BACTERIA STOOL IDENTIFIED | 1 0.01 10.92 BACTERIA TISSUE SPECIMEN IDENTIFIED | 1 0.01 10.93 BACTERIAL INFECTION | 1 0.01 10.94 BACTERIAL SEPSIS | 1 0.01 10.95 BALANCE DISORDER | 13 0.13 11.08 BASAL CELL CARCINOMA | 4 0.04 11.12 BEDRIDDEN | 2 0.02 11.14 BENIGN INTRACRANIAL HYPERTENSION | 3 0.03 11.17 BENIGN UTERINE NEOPLASM | 1 0.01 11.18 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 11.19 BICUSPID AORTIC VALVE | 1 0.01 11.20 BILE DUCT CANCER | 1 0.01 11.21 BILE DUCT STONE | 1 0.01 11.22 BILIARY TRACT DISORDER | 1 0.01 11.23 BIOPSY BREAST | 1 0.01 11.24 BIPOLAR I DISORDER | 2 0.02 11.26 BK VIRUS INFECTION | 1 0.01 11.27 BLADDER DISCOMFORT | 1 0.01 11.28 BLADDER DISORDER | 1 0.01 11.29 BLADDER DISTENSION | 1 0.01 11.30 BLADDER PAIN | 1 0.01 11.31 BLADDER PROLAPSE | 3 0.03 11.34 BLADDER SPASM | 2 0.02 11.36 BLAST CELL COUNT INCREASED | 1 0.01 11.37 BLEPHAROSPASM | 1 0.01 11.38 BLINDNESS | 11 0.11 11.49 BLINDNESS TRANSIENT | 1 0.01 11.50 BLINDNESS UNILATERAL | 4 0.04 11.54 BLISTER | 8 0.08 11.62 BLOOD ALBUMIN ABNORMAL | 1 0.01 11.63 BLOOD ALBUMIN DECREASED | 5 0.05 11.68 BLOOD ALBUMIN INCREASED | 1 0.01 11.69 BLOOD ALKALINE PHOSPHATASE DECREASED | 1 0.01 11.70 BLOOD ALKALINE PHOSPHATASE INCREASED | 16 0.16 11.86 BLOOD BILIRUBIN INCREASED | 4 0.04 11.90 BLOOD CALCIUM ABNORMAL | 1 0.01 11.91 BLOOD CALCIUM DECREASED | 2 0.02 11.93 BLOOD CALCIUM INCREASED | 6 0.06 11.99 BLOOD CHLORIDE DECREASED | 1 0.01 12.00 BLOOD CHOLESTEROL | 1 0.01 12.01 BLOOD CHOLESTEROL INCREASED | 22 0.22 12.23 BLOOD COUNT ABNORMAL | 2 0.02 12.25 BLOOD CREATINE INCREASED | 1 0.01 12.26 BLOOD CREATINE PHOSPHOKINASE INCREASED | 14 0.14 12.40 BLOOD CREATININE DECREASED | 1 0.01 12.41 BLOOD CREATININE INCREASED | 22 0.22 12.63 BLOOD CULTURE POSITIVE | 2 0.02 12.65 BLOOD DISORDER | 1 0.01 12.66 BLOOD FIBRINOGEN DECREASED | 1 0.01 12.67 BLOOD GLUCOSE ABNORMAL | 1 0.01 12.68 BLOOD GLUCOSE DECREASED | 9 0.09 12.77 BLOOD GLUCOSE FLUCTUATION | 2 0.02 12.79 BLOOD GLUCOSE INCREASED | 32 0.32 13.11 BLOOD HOMOCYSTEINE INCREASED | 1 0.01 13.12 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 13.13 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 13.14 BLOOD IMMUNOGLOBULIN G INCREASED | 1 0.01 13.15 BLOOD IRON DECREASED | 2 0.02 13.17 BLOOD LACTATE DEHYDROGENASE INCREASED | 4 0.04 13.21 BLOOD MAGNESIUM DECREASED | 2 0.02 13.23 BLOOD OESTROGEN INCREASED | 1 0.01 13.24 BLOOD PH DECREASED | 2 0.02 13.26 BLOOD POTASSIUM ABNORMAL | 1 0.01 13.27 BLOOD POTASSIUM DECREASED | 4 0.04 13.31 BLOOD POTASSIUM INCREASED | 7 0.07 13.38 BLOOD PRESSURE DECREASED | 11 0.11 13.49 BLOOD PRESSURE DIASTOLIC | 1 0.01 13.50 BLOOD PRESSURE FLUCTUATION | 3 0.03 13.53 BLOOD PRESSURE INADEQUATELY CONTROLLED | 4 0.04 13.57 BLOOD PRESSURE INCREASED | 26 0.26 13.83 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 13.84 BLOOD PRESSURE SYSTOLIC INCREASED | 2 0.02 13.86 BLOOD PROLACTIN INCREASED | 1 0.01 13.87 BLOOD SODIUM DECREASED | 6 0.06 13.93 BLOOD TEST ABNORMAL | 3 0.03 13.96 BLOOD TESTOSTERONE ABNORMAL | 1 0.01 13.97 BLOOD TESTOSTERONE DECREASED | 1 0.01 13.98 BLOOD TESTOSTERONE INCREASED | 2 0.02 14.00 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 14.04 BLOOD UREA INCREASED | 13 0.13 14.17 BLOOD URIC ACID INCREASED | 1 0.01 14.18 BLOOD URINE PRESENT | 3 0.03 14.21 BODY HEIGHT DECREASED | 7 0.07 14.28 BODY MASS INDEX DECREASED | 1 0.01 14.29 BODY TEMPERATURE DECREASED | 1 0.01 14.30 BODY TEMPERATURE INCREASED | 2 0.02 14.32 BONE CYST | 1 0.01 14.33 BONE DEBRIDEMENT | 5 0.05 14.38 BONE DENSITY DECREASED | 11 0.11 14.49 BONE DEVELOPMENT ABNORMAL | 1 0.01 14.50 BONE DISORDER | 13 0.13 14.63 BONE EROSION | 1 0.01 14.64 BONE LESION | 1 0.01 14.65 BONE MARROW DISORDER | 2 0.02 14.67 BONE MARROW FAILURE | 5 0.05 14.72 BONE MARROW OEDEMA | 1 0.01 14.73 BONE NEOPLASM MALIGNANT | 1 0.01 14.74 BONE PAIN | 43 0.43 15.17 BONE TRIMMING | 1 0.01 15.18 BOVINE TUBERCULOSIS | 1 0.01 15.19 BOWEN'S DISEASE | 1 0.01 15.20 BRADYCARDIA | 5 0.05 15.25 BRAIN ABSCESS | 2 0.02 15.27 BRAIN DAMAGE | 2 0.02 15.29 BRAIN DEATH | 1 0.01 15.30 BRAIN NATRIURETIC PEPTIDE INCREASED | 2 0.02 15.32 BRAIN NEOPLASM | 1 0.01 15.33 BRAIN NEOPLASM MALIGNANT | 1 0.01 15.34 BRAIN OEDEMA | 3 0.03 15.37 BREAKTHROUGH PAIN | 1 0.01 15.38 BREAST CANCER | 15 0.15 15.53 BREAST CANCER FEMALE | 4 0.04 15.57 BREAST CANCER METASTATIC | 10 0.10 15.67 BREAST CANCER RECURRENT | 4 0.04 15.71 BREAST CANCER STAGE I | 1 0.01 15.72 BREAST CYST | 1 0.01 15.73 BREAST DISCOMFORT | 1 0.01 15.74 BREAST DISORDER | 2 0.02 15.76 BREAST ENLARGEMENT | 1 0.01 15.77 BREAST NEOPLASM | 1 0.01 15.78 BREAST PAIN | 2 0.02 15.80 BREAST SWELLING | 4 0.04 15.84 BREAST TENDERNESS | 3 0.03 15.87 BREATH ODOUR | 1 0.01 15.88 BRONCHIAL HYPERREACTIVITY | 2 0.02 15.90 BRONCHITIS | 9 0.09 15.99 BRONCHITIS CHRONIC | 2 0.02 16.01 BRONCHOPNEUMONIA | 2 0.02 16.03 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 16.04 BRONCHOSPASM | 6 0.06 16.10 BRUGADA SYNDROME | 1 0.01 16.11 BRUXISM | 1 0.01 16.12 BUNDLE BRANCH BLOCK LEFT | 1 0.01 16.13 BUNDLE BRANCH BLOCK RIGHT | 5 0.05 16.18 BURNING SENSATION | 15 0.15 16.33 BURNS THIRD DEGREE | 2 0.02 16.35 BURSITIS | 2 0.02 16.37 C-REACTIVE PROTEIN INCREASED | 5 0.05 16.42 CACHEXIA | 1 0.01 16.43 CAECITIS | 1 0.01 16.44 CAESAREAN SECTION | 5 0.05 16.49 CALCINOSIS | 1 0.01 16.50 CALCIPHYLAXIS | 2 0.02 16.52 CALCIUM DEFICIENCY | 1 0.01 16.53 CALCULUS URETERIC | 2 0.02 16.55 CANDIDIASIS | 4 0.04 16.59 CARBOHYDRATE ANTIGEN 125 INCREASED | 2 0.02 16.61 CARDIAC ABLATION | 1 0.01 16.62 CARDIAC ARREST | 18 0.18 16.80 CARDIAC DEATH | 1 0.01 16.81 CARDIAC DISORDER | 24 0.24 17.05 CARDIAC FAILURE | 7 0.07 17.12 CARDIAC FAILURE ACUTE | 1 0.01 17.13 CARDIAC FAILURE CONGESTIVE | 12 0.12 17.25 CARDIAC FLUTTER | 1 0.01 17.26 CARDIAC HYPERTROPHY | 1 0.01 17.27 CARDIAC MURMUR | 5 0.05 17.32 CARDIAC NEOPLASM UNSPECIFIED | 1 0.01 17.33 CARDIAC OPERATION | 1 0.01 17.34 CARDIAC OUTPUT DECREASED | 1 0.01 17.35 CARDIAC SEPTAL DEFECT | 4 0.04 17.39 CARDIAC TAMPONADE | 2 0.02 17.41 CARDIAC VALVE DISEASE | 4 0.04 17.45 CARDIO-RESPIRATORY ARREST | 9 0.09 17.54 CARDIOGENIC SHOCK | 2 0.02 17.56 CARDIOMEGALY | 6 0.06 17.62 CARDIOMYOPATHY | 2 0.02 17.64 CARDIOPULMONARY FAILURE | 1 0.01 17.65 CARDIOTOXICITY | 1 0.01 17.66 CARDIOVASCULAR DISORDER | 2 0.02 17.68 CARNITINE DECREASED | 1 0.01 17.69 CAROTID ARTERY DISEASE | 1 0.01 17.70 CAROTID ARTERY STENOSIS | 1 0.01 17.71 CARPAL TUNNEL SYNDROME | 6 0.06 17.77 CATAPLEXY | 1 0.01 17.78 CATARACT | 13 0.13 17.91 CATARACT OPERATION | 3 0.03 17.94 CELL DEATH | 2 0.02 17.96 CELL MARKER INCREASED | 1 0.01 17.97 CELLULITIS | 3 0.03 18.00 CENTRAL NERVOUS SYSTEM INFLAMMATION | 1 0.01 18.01 CEPHALO-PELVIC DISPROPORTION | 1 0.01 18.02 CEREBELLAR SYNDROME | 1 0.01 18.03 CEREBRAL HAEMORRHAGE | 11 0.11 18.14 CEREBRAL INFARCTION | 10 0.10 18.24 CEREBRAL ISCHAEMIA | 2 0.02 18.26 CEREBROVASCULAR ACCIDENT | 53 0.53 18.79 CEREBROVASCULAR DISORDER | 1 0.01 18.80 CEREBROVASCULAR SPASM | 1 0.01 18.81 CERVICAL DYSPLASIA | 1 0.01 18.82 CERVICAL VERTEBRAL FRACTURE | 1 0.01 18.83 CERVIX CARCINOMA | 1 0.01 18.84 CHEILITIS | 4 0.04 18.88 CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THE.. | 1 0.01 18.89 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED | 2 0.02 18.91 CHEMOTHERAPY NEUROTOXICITY ATTENUATION | 1 0.01 18.92 CHEST DISCOMFORT | 22 0.22 19.14 CHEST PAIN | 27 0.27 19.41 CHILLS | 13 0.13 19.54 CHOKING | 5 0.05 19.59 CHOKING SENSATION | 1 0.01 19.60 CHOLECYSTECTOMY | 1 0.01 19.61 CHOLECYSTITIS ACUTE | 2 0.02 19.63 CHOLELITHIASIS | 6 0.06 19.69 CHOLESTASIS | 8 0.08 19.77 CHOREA | 1 0.01 19.78 CHOROIDAL NEOVASCULARISATION | 1 0.01 19.79 CHROMATOPSIA | 1 0.01 19.80 CHROMATURIA | 5 0.05 19.85 CHRONIC FATIGUE SYNDROME | 1 0.01 19.86 CHRONIC HEPATIC FAILURE | 1 0.01 19.87 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 19.88 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 5 0.05 19.93 CHRONIC SINUSITIS | 1 0.01 19.94 CIRCULATORY COLLAPSE | 3 0.03 19.97 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 1 0.01 19.98 CLEFT LIP AND PALATE | 2 0.02 20.00 CLOSTRIDIAL INFECTION | 1 0.01 20.01 CLOSTRIDIUM DIFFICILE TOXIN TEST | 1 0.01 20.02 CLUMSINESS | 1 0.01 20.03 COAGULOPATHY | 4 0.04 20.07 COARCTATION OF THE AORTA | 1 0.01 20.08 COCCIDIOIDOMYCOSIS | 1 0.01 20.09 COGNITIVE DISORDER | 7 0.07 20.16 COLD SWEAT | 2 0.02 20.18 COLECTOMY | 1 0.01 20.19 COLITIS | 12 0.12 20.31 COLITIS ISCHAEMIC | 1 0.01 20.32 COLITIS ULCERATIVE | 9 0.09 20.41 COLLAPSE OF LUNG | 2 0.02 20.43 COLON ADENOMA | 1 0.01 20.44 COLON CANCER | 1 0.01 20.45 COLON OPERATION | 1 0.01 20.46 COLONIC HAEMATOMA | 1 0.01 20.47 COLONIC POLYP | 1 0.01 20.48 COMA | 9 0.09 20.57 COMPLETED SUICIDE | 39 0.39 20.96 COMPLEX PARTIAL SEIZURES | 2 0.02 20.98 COMPLICATION OF PREGNANCY | 1 0.01 20.99 COMPLICATIONS OF TRANSPLANT SURGERY | 1 0.01 21.00 COMPLICATIONS OF TRANSPLANTED KIDNEY | 5 0.05 21.05 COMPRESSION FRACTURE | 3 0.03 21.08 COMPULSIONS | 1 0.01 21.09 COMPUTERISED TOMOGRAM | 2 0.02 21.11 COMPUTERISED TOMOGRAM ABNORMAL | 2 0.02 21.13 CONCOMITANT DISEASE PROGRESSION | 3 0.03 21.16 CONCUSSION | 1 0.01 21.17 CONDITION AGGRAVATED | 18 0.18 21.35 CONFUSIONAL STATE | 25 0.25 21.60 CONGENITAL ANOMALY | 4 0.04 21.64 CONGENITAL AORTIC ANOMALY | 1 0.01 21.65 CONGENITAL AORTIC VALVE INCOMPETENCE | 1 0.01 21.66 CONGENITAL FOOT MALFORMATION | 1 0.01 21.67 CONGENITAL HIP DEFORMITY | 1 0.01 21.68 CONGENITAL HYDRONEPHROSIS | 1 0.01 21.69 CONGESTIVE CARDIOMYOPATHY | 1 0.01 21.70 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 21.71 CONJUNCTIVITIS | 3 0.03 21.74 CONNECTIVE TISSUE DISORDER | 1 0.01 21.75 CONSCIOUSNESS FLUCTUATING | 1 0.01 21.76 CONSTIPATION | 28 0.28 22.04 CONTINUOUS HAEMODIAFILTRATION | 1 0.01 22.05 CONTRACTED BLADDER | 1 0.01 22.06 CONTUSION | 13 0.13 22.19 CONVERSION DISORDER | 1 0.01 22.20 CONVULSION | 49 0.49 22.69 CONVULSIONS LOCAL | 1 0.01 22.70 CONVULSIVE THRESHOLD LOWERED | 1 0.01 22.71 COOMBS TEST POSITIVE | 1 0.01 22.72 COORDINATION ABNORMAL | 3 0.03 22.75 CORONARY ARTERY BYPASS | 2 0.02 22.77 CORONARY ARTERY DISEASE | 8 0.08 22.85 CORONARY ARTERY OCCLUSION | 3 0.03 22.88 CORONARY ARTERY STENOSIS | 1 0.01 22.89 CORONARY ARTERY THROMBOSIS | 1 0.01 22.90 CORRECTIVE LENS USER | 1 0.01 22.91 COSTOCHONDRITIS | 3 0.03 22.94 COUGH | 40 0.40 23.34 CRANIAL NERVE DISORDER | 1 0.01 23.35 CRANIOPHARYNGIOMA | 1 0.01 23.36 CRANIOSYNOSTOSIS | 1 0.01 23.37 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 23.39 CROHN'S DISEASE | 9 0.09 23.48 CRYING | 14 0.14 23.62 CRYPTOCOCCOSIS | 1 0.01 23.63 CRYPTORCHISM | 1 0.01 23.64 CSF PROTEIN INCREASED | 1 0.01 23.65 CULTURE URINE POSITIVE | 1 0.01 23.66 CUSHING'S SYNDROME | 1 0.01 23.67 CUSHINGOID | 1 0.01 23.68 CYANOSIS | 8 0.08 23.76 CYST | 4 0.04 23.80 CYSTITIS | 6 0.06 23.86 CYSTITIS HAEMORRHAGIC | 3 0.03 23.89 CYTOLYTIC HEPATITIS | 4 0.04 23.93 CYTOMEGALOVIRUS INFECTION | 1 0.01 23.94 DACTYLITIS | 2 0.02 23.96 DEAFNESS | 1 0.01 23.97 DEAFNESS BILATERAL | 2 0.02 23.99 DEAFNESS NEUROSENSORY | 2 0.02 24.01 DEATH | 71 0.71 24.72 DECREASED ACTIVITY | 2 0.02 24.74 DECREASED APPETITE | 12 0.12 24.86 DECREASED INTEREST | 1 0.01 24.87 DECUBITUS ULCER | 1 0.01 24.88 DEEP VEIN THROMBOSIS | 12 0.12 25.00 DEFORMITY | 1 0.01 25.01 DEHYDRATION | 29 0.29 25.30 DELIRIUM | 6 0.06 25.36 DELUSION | 9 0.09 25.45 DEMENTIA | 4 0.04 25.49 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 25.50 DENTAL CARE | 2 0.02 25.52 DENTAL CARIES | 8 0.08 25.60 DENTAL OPERATION | 3 0.03 25.63 DENTAL PULP DISORDER | 1 0.01 25.64 DENTAL TREATMENT | 3 0.03 25.67 DEPENDENCE | 5 0.05 25.72 DEPRESSED LEVEL OF CONSCIOUSNESS | 5 0.05 25.77 DEPRESSED MOOD | 13 0.13 25.90 DEPRESSION | 88 0.88 26.78 DERMATITIS | 5 0.05 26.83 DERMATITIS ACNEIFORM | 1 0.01 26.84 DERMATITIS ALLERGIC | 1 0.01 26.85 DERMATITIS ATOPIC | 2 0.02 26.87 DERMATITIS BULLOUS | 2 0.02 26.89 DERMATITIS CONTACT | 1 0.01 26.90 DERMATITIS EXFOLIATIVE | 2 0.02 26.92 DERMATITIS EXFOLIATIVE GENERALISED | 1 0.01 26.93 DERMATOMYOSITIS | 1 0.01 26.94 DERMATOSIS | 2 0.02 26.96 DETACHMENT OF RETINAL PIGMENT EPITHEL.. | 3 0.03 26.99 DEVELOPMENTAL DELAY | 2 0.02 27.01 DEVICE FAILURE | 3 0.03 27.04 DEVICE MALFUNCTION | 2 0.02 27.06 DIABETES MELLITUS | 16 0.16 27.22 DIABETIC COMPLICATION | 1 0.01 27.23 DIABETIC HYPEROSMOLAR COMA | 2 0.02 27.25 DIABETIC KETOACIDOSIS | 7 0.07 27.32 DIABETIC NEUROPATHY | 1 0.01 27.33 DIABETIC RETINOPATHY | 1 0.01 27.34 DIALYSIS | 5 0.05 27.39 DIARRHOEA | 64 0.64 28.03 DIARRHOEA HAEMORRHAGIC | 1 0.01 28.04 DIFFUSE AXONAL INJURY | 1 0.01 28.05 DIPLOPIA | 13 0.13 28.18 DISABILITY | 4 0.04 28.22 DISCOMFORT | 7 0.07 28.29 DISEASE PROGRESSION | 19 0.19 28.48 DISEASE RECURRENCE | 3 0.03 28.51 DISINHIBITION | 1 0.01 28.52 DISORDER OF ORBIT | 1 0.01 28.53 DISORIENTATION | 6 0.06 28.59 DISSEMINATED INTRAVASCULAR COAGULATION | 7 0.07 28.66 DISSEMINATED TUBERCULOSIS | 2 0.02 28.68 DISSOCIATION | 1 0.01 28.69 DISTURBANCE IN ATTENTION | 12 0.12 28.81 DIVERTICULITIS | 5 0.05 28.86 DIVERTICULUM | 1 0.01 28.87 DIZZINESS | 86 0.86 29.73 DIZZINESS EXERTIONAL | 1 0.01 29.74 DIZZINESS POSTURAL | 1 0.01 29.75 DOCUMENTED HYPERSENSITIVITY TO ADMINI.. | 1 0.01 29.76 DREAMY STATE | 1 0.01 29.77 DRUG ABUSER | 4 0.04 29.81 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 2 0.02 29.83 DRUG ADMINISTRATION ERROR | 6 0.06 29.89 DRUG DEPENDENCE | 10 0.10 29.99 DRUG DISPENSING ERROR | 3 0.03 30.02 DRUG DOSE OMISSION | 2 0.02 30.04 DRUG EFFECT DECREASED | 15 0.15 30.19 DRUG EFFECT INCREASED | 1 0.01 30.20 DRUG ERUPTION | 5 0.05 30.25 DRUG EXPOSURE BEFORE PREGNANCY | 3 0.03 30.28 DRUG EXPOSURE DURING PREGNANCY | 67 0.67 30.95 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 30.96 DRUG HYPERSENSITIVITY | 11 0.11 31.07 DRUG INEFFECTIVE | 126 1.26 32.33 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 1 0.01 32.34 DRUG INTERACTION | 38 0.38 32.72 DRUG INTOLERANCE | 6 0.06 32.78 DRUG LEVEL ABOVE THERAPEUTIC | 2 0.02 32.80 DRUG LEVEL CHANGED | 1 0.01 32.81 DRUG LEVEL FLUCTUATING | 2 0.02 32.83 DRUG LEVEL INCREASED | 1 0.01 32.84 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 4 0.04 32.88 DRUG RESISTANCE | 2 0.02 32.90 DRUG TOLERANCE | 2 0.02 32.92 DRUG TOXICITY | 27 0.27 33.19 DRUG WITHDRAWAL CONVULSIONS | 1 0.01 33.20 DRUG WITHDRAWAL SYNDROME | 14 0.14 33.34 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 33.35 DRY EYE | 12 0.12 33.47 DRY MOUTH | 21 0.21 33.68 DRY SKIN | 11 0.11 33.79 DRY THROAT | 4 0.04 33.83 DUODENAL ULCER | 3 0.03 33.86 DUODENAL ULCER PERFORATION | 1 0.01 33.87 DUODENITIS | 1 0.01 33.88 DUODENOGASTRIC REFLUX | 1 0.01 33.89 DYSAESTHESIA | 2 0.02 33.91 DYSAESTHESIA PHARYNX | 1 0.01 33.92 DYSARTHRIA | 17 0.17 34.09 DYSGEUSIA | 25 0.25 34.34 DYSHIDROSIS | 1 0.01 34.35 DYSKINESIA | 5 0.05 34.40 DYSLALIA | 1 0.01 34.41 DYSPAREUNIA | 1 0.01 34.42 DYSPEPSIA | 18 0.18 34.60 DYSPHAGIA | 11 0.11 34.71 DYSPHASIA | 2 0.02 34.73 DYSPHEMIA | 2 0.02 34.75 DYSPHONIA | 10 0.10 34.85 DYSPNOEA | 100 1.00 35.85 DYSPNOEA EXERTIONAL | 6 0.06 35.91 DYSSTASIA | 5 0.05 35.96 DYSTONIA | 4 0.04 36.00 DYSURIA | 17 0.17 36.17 EAR DISCOMFORT | 1 0.01 36.18 EAR DISORDER | 2 0.02 36.20 EAR PAIN | 5 0.05 36.25 EAR PRURITUS | 1 0.01 36.26 EARLY SATIETY | 1 0.01 36.27 EATING DISORDER | 7 0.07 36.34 ECCHYMOSIS | 4 0.04 36.38 ECG SIGNS OF MYOCARDIAL ISCHAEMIA | 1 0.01 36.39 ECTOPIC PREGNANCY | 3 0.03 36.42 ECZEMA | 7 0.07 36.49 ECZEMA NUMMULAR | 1 0.01 36.50 EDENTULOUS | 1 0.01 36.51 EJACULATION DISORDER | 2 0.02 36.53 EJACULATION FAILURE | 1 0.01 36.54 EJECTION FRACTION DECREASED | 2 0.02 36.56 ELECTRIC SHOCK | 1 0.01 36.57 ELECTROCARDIOGRAM ABNORMAL | 2 0.02 36.59 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 36.60 ELECTROCARDIOGRAM QT PROLONGED | 6 0.06 36.66 ELECTROLYTE IMBALANCE | 2 0.02 36.68 EMBOLISM | 4 0.04 36.72 EMBOLISM VENOUS | 1 0.01 36.73 EMOTIONAL DISORDER | 4 0.04 36.77 EMOTIONAL DISTRESS | 7 0.07 36.84 EMPHYSEMA | 3 0.03 36.87 EMPYEMA | 1 0.01 36.88 ENCEPHALITIS | 2 0.02 36.90 ENCEPHALOPATHY | 8 0.08 36.98 ENCHONDROMATOSIS | 1 0.01 36.99 ENDODONTIC PROCEDURE | 2 0.02 37.01 ENDOMETRIAL HYPERPLASIA | 1 0.01 37.02 ENDOMETRIAL HYPERTROPHY | 2 0.02 37.04 ENDOMETRIAL NEOPLASM | 1 0.01 37.05 ENDOPHTHALMITIS | 5 0.05 37.10 ENERGY INCREASED | 3 0.03 37.13 ENTERITIS | 1 0.01 37.14 ENTERITIS INFECTIOUS | 1 0.01 37.15 ENTEROBACTER INFECTION | 1 0.01 37.16 ENURESIS | 1 0.01 37.17 EOSINOPHIL COUNT INCREASED | 2 0.02 37.19 EOSINOPHILIA | 5 0.05 37.24 EOSINOPHILIC PNEUMONIA | 1 0.01 37.25 EPIDIDYMITIS | 1 0.01 37.26 EPILEPSY | 5 0.05 37.31 EPISTAXIS | 10 0.10 37.41 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 37.43 EPSTEIN-BARR VIRUS TEST POSITIVE | 1 0.01 37.44 ERECTILE DYSFUNCTION | 2 0.02 37.46 ERUCTATION | 2 0.02 37.48 ERYSIPELAS | 2 0.02 37.50 ERYTHEMA | 22 0.22 37.72 ERYTHEMA MULTIFORME | 3 0.03 37.75 ERYTHEMA NODOSUM | 1 0.01 37.76 ERYTHROBLASTOSIS | 1 0.01 37.77 ESCHAR | 1 0.01 37.78 ESCHERICHIA INFECTION | 2 0.02 37.80 ESCHERICHIA SEPSIS | 2 0.02 37.82 ESCHERICHIA URINARY TRACT INFECTION | 3 0.03 37.85 EUPHORIC MOOD | 1 0.01 37.86 EUSTACHIAN TUBE DISORDER | 1 0.01 37.87 EUSTACHIAN TUBE DYSFUNCTION | 1 0.01 37.88 EXCESSIVE GRANULATION TISSUE | 1 0.01 37.89 EXCORIATION | 2 0.02 37.91 EXERCISE TOLERANCE DECREASED | 1 0.01 37.92 EXFOLIATIVE RASH | 1 0.01 37.93 EXOMPHALOS | 2 0.02 37.95 EXOSTOSIS | 1 0.01 37.96 EXPIRED DRUG ADMINISTERED | 2 0.02 37.98 EXPRESSIVE LANGUAGE DISORDER | 1 0.01 37.99 EXTRAPYRAMIDAL DISORDER | 1 0.01 38.00 EXTRASYSTOLES | 1 0.01 38.01 EXTREMITY NECROSIS | 2 0.02 38.03 EYE DISCHARGE | 1 0.01 38.04 EYE DISORDER | 7 0.07 38.11 EYE HAEMORRHAGE | 2 0.02 38.13 EYE INFECTION | 1 0.01 38.14 EYE INFLAMMATION | 1 0.01 38.15 EYE IRRITATION | 3 0.03 38.18 EYE MOVEMENT DISORDER | 1 0.01 38.19 EYE OEDEMA | 1 0.01 38.20 EYE PAIN | 5 0.05 38.25 EYE ROLLING | 1 0.01 38.26 EYE SWELLING | 7 0.07 38.33 EYELID FUNCTION DISORDER | 1 0.01 38.34 EYELID OEDEMA | 4 0.04 38.38 EYELID PTOSIS | 1 0.01 38.39 FACE INJURY | 1 0.01 38.40 FACE OEDEMA | 6 0.06 38.46 FACIAL BONES FRACTURE | 2 0.02 38.48 FACIAL PAIN | 1 0.01 38.49 FACIAL PALSY | 4 0.04 38.53 FACIAL PARESIS | 2 0.02 38.55 FAECES DISCOLOURED | 5 0.05 38.60 FAILURE TO THRIVE | 1 0.01 38.61 FALL | 62 0.62 39.23 FALLOT'S TETRALOGY | 2 0.02 39.25 FAMILY STRESS | 1 0.01 39.26 FAT EMBOLISM | 1 0.01 39.27 FATIGUE | 99 0.99 40.26 FEAR | 4 0.04 40.30 FEAR OF DEATH | 1 0.01 40.31 FEBRILE BONE MARROW APLASIA | 1 0.01 40.32 FEBRILE NEUTROPENIA | 8 0.08 40.40 FEEDING DISORDER | 2 0.02 40.42 FEEDING TUBE COMPLICATION | 1 0.01 40.43 FEELING ABNORMAL | 41 0.41 40.84 FEELING COLD | 9 0.09 40.93 FEELING DRUNK | 3 0.03 40.96 FEELING HOT | 12 0.12 41.08 FEELING JITTERY | 5 0.05 41.13 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 41.14 FEELING OF DESPAIR | 1 0.01 41.15 FEELING OF RELAXATION | 1 0.01 41.16 FEELINGS OF WORTHLESSNESS | 2 0.02 41.18 FEMUR FRACTURE | 1 0.01 41.19 FIBRIN D DIMER INCREASED | 1 0.01 41.20 FIBRIN DEGRADATION PRODUCTS INCREASED | 1 0.01 41.21 FIBROADENOMA OF BREAST | 1 0.01 41.22 FIBROMYALGIA | 2 0.02 41.24 FIBULA FRACTURE | 1 0.01 41.25 FINGER DEFORMITY | 1 0.01 41.26 FISTULA | 1 0.01 41.27 FISTULA DISCHARGE | 1 0.01 41.28 FLAIL CHEST | 1 0.01 41.29 FLANK PAIN | 3 0.03 41.32 FLATULENCE | 10 0.10 41.42 FLOPPY IRIS SYNDROME | 1 0.01 41.43 FLUID RETENTION | 6 0.06 41.49 FLUSHING | 9 0.09 41.58 FOAMING AT MOUTH | 2 0.02 41.60 FOETAL DISORDER | 1 0.01 41.61 FOETAL GROWTH RETARDATION | 3 0.03 41.64 FOETAL HEART RATE ABNORMAL | 2 0.02 41.66 FOLLICULITIS | 2 0.02 41.68 FOOD ALLERGY | 1 0.01 41.69 FOOD CRAVING | 1 0.01 41.70 FOOD INTERACTION | 1 0.01 41.71 FOOD POISONING | 1 0.01 41.72 FOOT DEFORMITY | 1 0.01 41.73 FOOT FRACTURE | 6 0.06 41.79 FOOT OPERATION | 1 0.01 41.80 FOREIGN BODY SENSATION IN EYES | 1 0.01 41.81 FOREIGN BODY TRAUMA | 1 0.01 41.82 FORMICATION | 2 0.02 41.84 FRACTURE | 1 0.01 41.85 FREQUENT BOWEL MOVEMENTS | 2 0.02 41.87 FRUSTRATION | 1 0.01 41.88 FUNGAEMIA | 1 0.01 41.89 FUNGAL INFECTION | 3 0.03 41.92 FUNGAL SKIN INFECTION | 1 0.01 41.93 FUNGUS URINE TEST POSITIVE | 1 0.01 41.94 FURUNCLE | 1 0.01 41.95 GAIT DISTURBANCE | 39 0.39 42.34 GALLBLADDER DISORDER | 1 0.01 42.35 GALLBLADDER ENLARGEMENT | 1 0.01 42.36 GALLBLADDER OPERATION | 3 0.03 42.39 GAMBLING | 1 0.01 42.40 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL | 1 0.01 42.41 GAMMA-GLUTAMYLTRANSFERASE DECREASED | 1 0.01 42.42 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 10 0.10 42.52 GANGRENE | 1 0.01 42.53 GASTRECTOMY | 1 0.01 42.54 GASTRIC CANCER | 5 0.05 42.59 GASTRIC DISORDER | 4 0.04 42.63 GASTRIC HAEMORRHAGE | 3 0.03 42.66 GASTRIC INFECTION | 1 0.01 42.67 GASTRIC OPERATION | 1 0.01 42.68 GASTRIC PH DECREASED | 1 0.01 42.69 GASTRIC ULCER | 3 0.03 42.72 GASTRIC ULCER HAEMORRHAGE | 1 0.01 42.73 GASTRIC ULCER HELICOBACTER | 1 0.01 42.74 GASTRITIS | 2 0.02 42.76 GASTRITIS EROSIVE | 1 0.01 42.77 GASTRODUODENITIS | 1 0.01 42.78 GASTROENTERITIS | 1 0.01 42.79 GASTROENTERITIS BACTERIAL | 1 0.01 42.80 GASTROENTERITIS EOSINOPHILIC | 1 0.01 42.81 GASTROINTESTINAL CARCINOMA | 1 0.01 42.82 GASTROINTESTINAL DISORDER | 9 0.09 42.91 GASTROINTESTINAL HAEMORRHAGE | 5 0.05 42.96 GASTROINTESTINAL INFECTION | 3 0.03 42.99 GASTROINTESTINAL INFLAMMATION | 1 0.01 43.00 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 43.01 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 43.02 GASTROINTESTINAL OEDEMA | 1 0.01 43.03 GASTROINTESTINAL PAIN | 2 0.02 43.05 GASTROINTESTINAL PERFORATION | 1 0.01 43.06 GASTROINTESTINAL SOUNDS ABNORMAL | 2 0.02 43.08 GASTROINTESTINAL TUBE INSERTION | 1 0.01 43.09 GASTROOESOPHAGEAL REFLUX DISEASE | 10 0.10 43.19 GAZE PALSY | 1 0.01 43.20 GENERAL PHYSICAL CONDITION | 1 0.01 43.21 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 43.22 GENERAL PHYSICAL HEALTH DETERIORATION | 13 0.13 43.35 GENERALISED ERYTHEMA | 6 0.06 43.41 GENERALISED OEDEMA | 4 0.04 43.45 GENITAL HAEMORRHAGE | 1 0.01 43.46 GINGIVAL BLEEDING | 5 0.05 43.51 GINGIVAL BLISTER | 1 0.01 43.52 GINGIVAL CYST | 1 0.01 43.53 GINGIVAL INFECTION | 2 0.02 43.55 GINGIVAL PAIN | 2 0.02 43.57 GINGIVAL SWELLING | 1 0.01 43.58 GINGIVITIS | 4 0.04 43.62 GLAUCOMA | 1 0.01 43.63 GLIOSIS | 2 0.02 43.65 GLOMERULAR FILTRATION RATE DECREASED | 2 0.02 43.67 GLOSSODYNIA | 5 0.05 43.72 GLUCOSE URINE PRESENT | 1 0.01 43.73 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 43.74 GOITRE | 1 0.01 43.75 GOUT | 2 0.02 43.77 GOUTY ARTHRITIS | 1 0.01 43.78 GRAFT COMPLICATION | 1 0.01 43.79 GRAFT INFECTION | 2 0.02 43.81 GRAFT VERSUS HOST DISEASE | 2 0.02 43.83 GRAND MAL CONVULSION | 9 0.09 43.92 GRANDIOSITY | 1 0.01 43.93 GRANULOCYTES MATURATION ARREST | 1 0.01 43.94 GRANULOCYTOPENIA | 1 0.01 43.95 GRANULOMA | 1 0.01 43.96 GRANULOMA ANNULARE | 1 0.01 43.97 GRANULOMATOUS LIVER DISEASE | 1 0.01 43.98 GRIP STRENGTH DECREASED | 1 0.01 43.99 GROIN PAIN | 4 0.04 44.03 GUILLAIN-BARRE SYNDROME | 4 0.04 44.07 GUN SHOT WOUND | 1 0.01 44.08 GYNAECOMASTIA | 1 0.01 44.09 HAEMANGIOMA | 2 0.02 44.11 HAEMATEMESIS | 8 0.08 44.19 HAEMATOCHEZIA | 9 0.09 44.28 HAEMATOCRIT DECREASED | 10 0.10 44.38 HAEMATOCRIT INCREASED | 1 0.01 44.39 HAEMATOMA | 7 0.07 44.46 HAEMATOMA EVACUATION | 2 0.02 44.48 HAEMATOTOXICITY | 1 0.01 44.49 HAEMATURIA | 14 0.14 44.63 HAEMODIALYSIS | 7 0.07 44.70 HAEMODYNAMIC INSTABILITY | 2 0.02 44.72 HAEMOGLOBIN ABNORMAL | 1 0.01 44.73 HAEMOGLOBIN DECREASED | 19 0.19 44.92 HAEMOLYSIS | 1 0.01 44.93 HAEMOLYTIC ANAEMIA | 2 0.02 44.95 HAEMOPHILIA | 1 0.01 44.96 HAEMOPTYSIS | 5 0.05 45.01 HAEMORRHAGE | 18 0.18 45.19 HAEMORRHAGIC ANAEMIA | 1 0.01 45.20 HAEMORRHAGIC ASCITES | 1 0.01 45.21 HAEMORRHAGIC DIATHESIS | 1 0.01 45.22 HAEMORRHAGIC DISORDER | 1 0.01 45.23 HAEMORRHAGIC STROKE | 2 0.02 45.25 HAEMORRHAGIC TUMOUR NECROSIS | 1 0.01 45.26 HAEMORRHOIDS | 4 0.04 45.30 HAEMOTHORAX | 1 0.01 45.31 HAIR COLOUR CHANGES | 1 0.01 45.32 HAIR DISORDER | 5 0.05 45.37 HAIR GROWTH ABNORMAL | 7 0.07 45.44 HAIR TEXTURE ABNORMAL | 7 0.07 45.51 HALLUCINATION | 24 0.24 45.75 HALLUCINATION, AUDITORY | 6 0.06 45.81 HALLUCINATION, VISUAL | 5 0.05 45.86 HALLUCINATIONS, MIXED | 1 0.01 45.87 HAND DEFORMITY | 1 0.01 45.88 HAND FRACTURE | 1 0.01 45.89 HAPTOGLOBIN DECREASED | 1 0.01 45.90 HBV DNA INCREASED | 1 0.01 45.91 HEAD DISCOMFORT | 1 0.01 45.92 HEAD INJURY | 5 0.05 45.97 HEADACHE | 103 1.03 47.00 HEARING IMPAIRED | 2 0.02 47.02 HEART DISEASE CONGENITAL | 5 0.05 47.07 HEART INJURY | 3 0.03 47.10 HEART RATE DECREASED | 5 0.05 47.15 HEART RATE INCREASED | 12 0.12 47.27 HEART RATE IRREGULAR | 1 0.01 47.28 HEART TRANSPLANT REJECTION | 1 0.01 47.29 HEART VALVE INCOMPETENCE | 1 0.01 47.30 HELICOBACTER INFECTION | 2 0.02 47.32 HELLP SYNDROME | 1 0.01 47.33 HEMIPARESIS | 5 0.05 47.38 HEMIPLEGIA | 1 0.01 47.39 HEPATIC ATROPHY | 1 0.01 47.40 HEPATIC CIRRHOSIS | 8 0.08 47.48 HEPATIC ENCEPHALOPATHY | 1 0.01 47.49 HEPATIC ENZYME INCREASED | 14 0.14 47.63 HEPATIC FAILURE | 10 0.10 47.73 HEPATIC FIBROSIS | 1 0.01 47.74 HEPATIC FUNCTION ABNORMAL | 14 0.14 47.88 HEPATIC HAEMATOMA | 1 0.01 47.89 HEPATIC INFECTION | 1 0.01 47.90 HEPATIC NEOPLASM | 2 0.02 47.92 HEPATIC NEOPLASM MALIGNANT | 1 0.01 47.93 HEPATIC PAIN | 1 0.01 47.94 HEPATIC STEATOSIS | 1 0.01 47.95 HEPATITIS | 6 0.06 48.01 HEPATITIS A | 1 0.01 48.02 HEPATITIS ACUTE | 3 0.03 48.05 HEPATITIS B | 4 0.04 48.09 HEPATITIS C | 1 0.01 48.10 HEPATITIS CHOLESTATIC | 1 0.01 48.11 HEPATITIS FULMINANT | 3 0.03 48.14 HEPATOCELLULAR DAMAGE | 2 0.02 48.16 HEPATOMEGALY | 2 0.02 48.18 HEPATOSPLENOMEGALY | 2 0.02 48.20 HEPATOTOXICITY | 1 0.01 48.21 HERNIA | 3 0.03 48.24 HERNIA REPAIR | 1 0.01 48.25 HERPES SIMPLEX | 1 0.01 48.26 HERPES SIMPLEX DNA TEST POSITIVE | 1 0.01 48.27 HERPES ZOSTER | 6 0.06 48.33 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 48.35 HIP ARTHROPLASTY | 1 0.01 48.36 HIP DYSPLASIA | 1 0.01 48.37 HIP FRACTURE | 7 0.07 48.44 HIP SWELLING | 1 0.01 48.45 HIRSUTISM | 2 0.02 48.47 HISTIOCYTOSIS HAEMATOPHAGIC | 3 0.03 48.50 HISTOPLASMOSIS DISSEMINATED | 3 0.03 48.53 HIV INFECTION | 3 0.03 48.56 HODGKIN'S DISEASE | 1 0.01 48.57 HODGKIN'S DISEASE LYMPHOCYTE DEPLETIO.. | 1 0.01 48.58 HOMICIDAL IDEATION | 5 0.05 48.63 HORMONE LEVEL ABNORMAL | 1 0.01 48.64 HOSPITALISATION | 11 0.11 48.75 HOSTILITY | 3 0.03 48.78 HOT FLUSH | 91 0.91 49.69 HUMAN EHRLICHIOSIS | 1 0.01 49.70 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE | 1 0.01 49.71 HUNGER | 2 0.02 49.73 HYDROCELE | 1 0.01 49.74 HYDROCELE EXCISION | 2 0.02 49.76 HYDRONEPHROSIS | 3 0.03 49.79 HYPERACUSIS | 2 0.02 49.81 HYPERAEMIA | 1 0.01 49.82 HYPERAESTHESIA | 1 0.01 49.83 HYPERBARIC OXYGEN THERAPY | 2 0.02 49.85 HYPERBILIRUBINAEMIA | 4 0.04 49.89 HYPERCALCAEMIA | 5 0.05 49.94 HYPERCALCIURIA | 1 0.01 49.95 HYPERCAPNIA | 2 0.02 49.97 HYPERCHOLESTEROLAEMIA | 2 0.02 49.99 HYPERCHROMIC ANAEMIA | 1 0.01 50.00 HYPERCREATININAEMIA | 1 0.01 50.01 HYPERGLYCAEMIA | 9 0.09 50.10 HYPERHIDROSIS | 24 0.24 50.34 HYPERKALAEMIA | 4 0.04 50.38 HYPERLIPIDAEMIA | 1 0.01 50.39 HYPERMETROPIA | 1 0.01 50.40 HYPERNATRAEMIA | 1 0.01 50.41 HYPEROSMOLAR STATE | 1 0.01 50.42 HYPERPHAGIA | 2 0.02 50.44 HYPERPLASIA | 1 0.01 50.45 HYPERPYREXIA | 1 0.01 50.46 HYPERSENSITIVITY | 19 0.19 50.65 HYPERSOMNIA | 6 0.06 50.71 HYPERTENSION | 49 0.49 51.20 HYPERTENSIVE CARDIOMYOPATHY | 1 0.01 51.21 HYPERTENSIVE CRISIS | 1 0.01 51.22 HYPERTENSIVE ENCEPHALOPATHY | 1 0.01 51.23 HYPERTHERMIA | 2 0.02 51.25 HYPERTHYROIDISM | 1 0.01 51.26 HYPERTONIA | 4 0.04 51.30 HYPERTRICHOSIS | 2 0.02 51.32 HYPERURICAEMIA | 1 0.01 51.33 HYPERVENTILATION | 3 0.03 51.36 HYPHAEMA | 1 0.01 51.37 HYPOACUSIS | 1 0.01 51.38 HYPOAESTHESIA | 36 0.36 51.74 HYPOAESTHESIA FACIAL | 2 0.02 51.76 HYPOAESTHESIA ORAL | 2 0.02 51.78 HYPOALBUMINAEMIA | 2 0.02 51.80 HYPOCALCAEMIA | 2 0.02 51.82 HYPOCHROMIC ANAEMIA | 1 0.01 51.83 HYPOGAMMAGLOBULINAEMIA | 1 0.01 51.84 HYPOGLYCAEMIA | 8 0.08 51.92 HYPOGLYCAEMIA NEONATAL | 1 0.01 51.93 HYPOGLYCAEMIC SEIZURE | 1 0.01 51.94 HYPOGLYCAEMIC UNCONSCIOUSNESS | 2 0.02 51.96 HYPOKALAEMIA | 9 0.09 52.05 HYPOKINESIA | 2 0.02 52.07 HYPOMAGNESAEMIA | 1 0.01 52.08 HYPOMANIA | 1 0.01 52.09 HYPONATRAEMIA | 7 0.07 52.16 HYPOPITUITARISM | 1 0.01 52.17 HYPOPLASTIC LEFT HEART SYNDROME | 2 0.02 52.19 HYPOPROTEINAEMIA | 2 0.02 52.21 HYPOREFLEXIA | 1 0.01 52.22 HYPOTENSION | 40 0.40 52.62 HYPOTHYROIDISM | 13 0.13 52.75 HYPOTONIA | 4 0.04 52.79 HYPOTONIA NEONATAL | 1 0.01 52.80 HYPOVENTILATION | 1 0.01 52.81 HYPOVOLAEMIA | 2 0.02 52.83 HYPOVOLAEMIC SHOCK | 2 0.02 52.85 HYPOXIA | 5 0.05 52.90 HYSTERECTOMY | 2 0.02 52.92 IATROGENIC INJURY | 1 0.01 52.93 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 52.94 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 52.95 IDIOSYNCRATIC DRUG REACTION | 1 0.01 52.96 ILEAL STENOSIS | 1 0.01 52.97 ILEITIS | 1 0.01 52.98 ILEUS | 2 0.02 53.00 ILL-DEFINED DISORDER | 42 0.42 53.42 IMMOBILE | 1 0.01 53.43 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 53.44 IMMUNE SYSTEM DISORDER | 1 0.01 53.45 IMMUNODEFICIENCY | 1 0.01 53.46 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED | 3 0.03 53.49 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 53.50 IMMUNOSUPPRESSION | 1 0.01 53.51 IMPAIRED DRIVING ABILITY | 1 0.01 53.52 IMPAIRED HEALING | 9 0.09 53.61 IMPATIENCE | 2 0.02 53.63 IMPETIGO | 1 0.01 53.64 IMPLANT SITE REACTION | 1 0.01 53.65 IMPLANTABLE DEFIBRILLATOR INSERTION | 1 0.01 53.66 IMPULSE-CONTROL DISORDER | 1 0.01 53.67 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 53.69 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 1 0.01 53.70 INCISION SITE INFECTION | 1 0.01 53.71 INCISION SITE PAIN | 3 0.03 53.74 INCISIONAL DRAINAGE | 1 0.01 53.75 INCISIONAL HERNIA | 1 0.01 53.76 INCOHERENT | 4 0.04 53.80 INCONTINENCE | 1 0.01 53.81 INCORRECT DOSE ADMINISTERED | 6 0.06 53.87 INCORRECT DRUG ADMINISTRATION DURATION | 1 0.01 53.88 INCORRECT ROUTE OF DRUG ADMINISTRATION | 9 0.09 53.97 INCREASED APPETITE | 4 0.04 54.01 INCREASED TENDENCY TO BRUISE | 1 0.01 54.02 INCREASED UPPER AIRWAY SECRETION | 6 0.06 54.08 INCREASED VISCOSITY OF BRONCHIAL SECR.. | 1 0.01 54.09 INDUCED LABOUR | 1 0.01 54.10 INDURATION | 1 0.01 54.11 INFARCTION | 3 0.03 54.14 INFECTED INSECT BITE | 1 0.01 54.15 INFECTION | 18 0.18 54.33 INFECTIOUS MONONUCLEOSIS | 1 0.01 54.34 INFERIORITY COMPLEX | 1 0.01 54.35 INFERTILITY | 1 0.01 54.36 INFLAMMATION | 6 0.06 54.42 INFLAMMATORY BOWEL DISEASE | 7 0.07 54.49 INFLUENZA | 6 0.06 54.55 INFLUENZA LIKE ILLNESS | 19 0.19 54.74 INFREQUENT BOWEL MOVEMENTS | 1 0.01 54.75 INFUSION RELATED REACTION | 7 0.07 54.82 INFUSION SITE RASH | 1 0.01 54.83 INITIAL INSOMNIA | 2 0.02 54.85 INJECTION SITE ABSCESS | 1 0.01 54.86 INJECTION SITE ANAESTHESIA | 2 0.02 54.88 INJECTION SITE BRUISING | 4 0.04 54.92 INJECTION SITE DISCOLOURATION | 1 0.01 54.93 INJECTION SITE ERYTHEMA | 8 0.08 55.01 INJECTION SITE HAEMORRHAGE | 5 0.05 55.06 INJECTION SITE INDURATION | 2 0.02 55.08 INJECTION SITE INFECTION | 2 0.02 55.10 INJECTION SITE IRRITATION | 4 0.04 55.14 INJECTION SITE NECROSIS | 1 0.01 55.15 INJECTION SITE PAIN | 7 0.07 55.22 INJECTION SITE PHLEBITIS | 1 0.01 55.23 INJECTION SITE RASH | 2 0.02 55.25 INJECTION SITE REACTION | 3 0.03 55.28 INJECTION SITE SWELLING | 2 0.02 55.30 INJECTION SITE VESICLES | 1 0.01 55.31 INJURY | 7 0.07 55.38 INSOMNIA | 67 0.67 56.05 INTENTIONAL DRUG MISUSE | 4 0.04 56.09 INTENTIONAL OVERDOSE | 13 0.13 56.22 INTENTIONAL SELF-INJURY | 3 0.03 56.25 INTERMITTENT CLAUDICATION | 2 0.02 56.27 INTERMITTENT POSITIVE PRESSURE BREATH.. | 2 0.02 56.29 INTERNAL INJURY | 1 0.01 56.30 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 56.31 INTERNATIONAL NORMALISED RATIO INCREA.. | 9 0.09 56.40 INTERSTITIAL LUNG DISEASE | 15 0.15 56.55 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 56.56 INTERVERTEBRAL DISC PROTRUSION | 6 0.06 56.62 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 56.63 INTESTINAL HAEMORRHAGE | 3 0.03 56.66 INTESTINAL INFARCTION | 1 0.01 56.67 INTESTINAL ISCHAEMIA | 2 0.02 56.69 INTESTINAL OBSTRUCTION | 5 0.05 56.74 INTESTINAL OPERATION | 1 0.01 56.75 INTESTINAL PERFORATION | 2 0.02 56.77 INTESTINAL RESECTION | 3 0.03 56.80 INTRA-ABDOMINAL HAEMATOMA | 2 0.02 56.82 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 56.83 INTRA-UTERINE DEATH | 1 0.01 56.84 INTRACRANIAL HAEMATOMA | 1 0.01 56.85 INTRACRANIAL HYPOTENSION | 1 0.01 56.86 INTRACRANIAL VENOUS SINUS THROMBOSIS | 2 0.02 56.88 INTRAUTERINE INFECTION | 1 0.01 56.89 INTUBATION | 3 0.03 56.92 IRIDOCELE | 1 0.01 56.93 IRIS DISORDER | 1 0.01 56.94 IRIS INJURY | 1 0.01 56.95 IRON DEFICIENCY ANAEMIA | 1 0.01 56.96 IRON OVERLOAD | 1 0.01 56.97 IRREGULAR SLEEP PHASE | 1 0.01 56.98 IRRITABILITY | 15 0.15 57.13 IRRITABLE BOWEL SYNDROME | 4 0.04 57.17 ISCHAEMIA | 1 0.01 57.18 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 57.19 ISCHAEMIC STROKE | 2 0.02 57.21 JAPAN COMA SCALE ABNORMAL | 2 0.02 57.23 JAUNDICE | 10 0.10 57.33 JAUNDICE NEONATAL | 1 0.01 57.34 JAW DISORDER | 3 0.03 57.37 JAW OPERATION | 1 0.01 57.38 JOINT DISLOCATION | 3 0.03 57.41 JOINT INJURY | 5 0.05 57.46 JOINT LOCK | 1 0.01 57.47 JOINT STIFFNESS | 9 0.09 57.56 JOINT SWELLING | 14 0.14 57.70 JUGULAR VEIN THROMBOSIS | 1 0.01 57.71 KETOACIDOSIS | 1 0.01 57.72 KETONURIA | 1 0.01 57.73 KIDNEY INFECTION | 4 0.04 57.77 KIDNEY TRANSPLANT REJECTION | 1 0.01 57.78 KLEBSIELLA INFECTION | 1 0.01 57.79 KNEE ARTHROPLASTY | 4 0.04 57.83 LABORATORY TEST ABNORMAL | 1 0.01 57.84 LACRIMAL DISORDER | 1 0.01 57.85 LACRIMATION INCREASED | 5 0.05 57.90 LACTIC ACIDOSIS | 3 0.03 57.93 LACTOSE INTOLERANCE | 3 0.03 57.96 LARGE INTESTINE CARCINOMA | 2 0.02 57.98 LARYNGEAL DYSPNOEA | 1 0.01 57.99 LARYNGEAL OEDEMA | 1 0.01 58.00 LARYNGEAL PAPILLOMA | 1 0.01 58.01 LARYNGITIS | 3 0.03 58.04 LARYNGOSPASM | 2 0.02 58.06 LASER THERAPY | 1 0.01 58.07 LEFT VENTRICULAR DYSFUNCTION | 4 0.04 58.11 LEFT VENTRICULAR END-DIASTOLIC PRESSU.. | 1 0.01 58.12 LEFT VENTRICULAR HYPERTROPHY | 1 0.01 58.13 LEG AMPUTATION | 1 0.01 58.14 LETHARGY | 7 0.07 58.21 LEUKAEMIA | 2 0.02 58.23 LEUKAEMIA RECURRENT | 1 0.01 58.24 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 58.27 LEUKOCYTOSIS | 4 0.04 58.31 LEUKOENCEPHALOPATHY | 1 0.01 58.32 LEUKOPENIA | 11 0.11 58.43 LIBIDO DECREASED | 1 0.01 58.44 LICE INFESTATION | 1 0.01 58.45 LIMB DISCOMFORT | 1 0.01 58.46 LIMB INJURY | 2 0.02 58.48 LIMB MALFORMATION | 3 0.03 58.51 LIMB OPERATION | 1 0.01 58.52 LIP BLISTER | 1 0.01 58.53 LIP DISCOLOURATION | 1 0.01 58.54 LIP DISORDER | 1 0.01 58.55 LIP DRY | 2 0.02 58.57 LIP EROSION | 1 0.01 58.58 LIP HAEMORRHAGE | 1 0.01 58.59 LIP OEDEMA | 1 0.01 58.60 LIP PAIN | 2 0.02 58.62 LIP SWELLING | 8 0.08 58.70 LIP ULCERATION | 1 0.01 58.71 LIPODYSTROPHY ACQUIRED | 1 0.01 58.72 LIPOMATOSIS | 1 0.01 58.73 LISTERIA ENCEPHALITIS | 1 0.01 58.74 LISTERIOSIS | 1 0.01 58.75 LIVEDO RETICULARIS | 1 0.01 58.76 LIVER DISORDER | 6 0.06 58.82 LIVER FUNCTION TEST ABNORMAL | 5 0.05 58.87 LIVER OPERATION | 1 0.01 58.88 LIVER PALPABLE SUBCOSTAL | 1 0.01 58.89 LOCAL SWELLING | 2 0.02 58.91 LOCALISED INFECTION | 1 0.01 58.92 LOCALISED OEDEMA | 2 0.02 58.94 LOGORRHOEA | 1 0.01 58.95 LOOSE TOOTH | 1 0.01 58.96 LOSS OF CONSCIOUSNESS | 49 0.49 59.45 LOSS OF CONTROL OF LEGS | 1 0.01 59.46 LOSS OF EMPLOYMENT | 1 0.01 59.47 LOW DENSITY LIPOPROTEIN INCREASED | 3 0.03 59.50 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 59.51 LOWER LIMB FRACTURE | 3 0.03 59.54 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 59.56 LOWER RESPIRATORY TRACT INFECTION BAC.. | 1 0.01 59.57 LUMBAR SPINAL STENOSIS | 1 0.01 59.58 LUMBAR VERTEBRAL FRACTURE | 1 0.01 59.59 LUNG ADENOCARCINOMA | 1 0.01 59.60 LUNG CYST BENIGN | 1 0.01 59.61 LUNG DISORDER | 8 0.08 59.69 LUNG INFECTION | 3 0.03 59.72 LUNG INFECTION PSEUDOMONAL | 1 0.01 59.73 LUNG INFILTRATION | 4 0.04 59.77 LUNG INJURY | 2 0.02 59.79 LUNG LOBECTOMY | 1 0.01 59.80 LUNG NEOPLASM MALIGNANT | 8 0.08 59.88 LUPUS-LIKE SYNDROME | 2 0.02 59.90 LYMPH NODE CANCER METASTATIC | 1 0.01 59.91 LYMPHADENITIS | 1 0.01 59.92 LYMPHADENOPATHY | 5 0.05 59.97 LYMPHANGIOSIS CARCINOMATOSA | 1 0.01 59.98 LYMPHOCYTE COUNT DECREASED | 3 0.03 60.01 LYMPHOCYTE MORPHOLOGY ABNORMAL | 1 0.01 60.02 LYMPHOEDEMA | 4 0.04 60.06 LYMPHOMA | 2 0.02 60.08 LYMPHOPENIA | 5 0.05 60.13 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 60.14 MACROGLOSSIA | 1 0.01 60.15 MACROSOMIA | 1 0.01 60.16 MACULAR DEGENERATION | 7 0.07 60.23 MACULAR HOLE | 1 0.01 60.24 MACULAR OEDEMA | 1 0.01 60.25 MAJOR DEPRESSION | 1 0.01 60.26 MALAISE | 49 0.49 60.75 MALIGNANT BREAST LUMP REMOVAL | 1 0.01 60.76 MALIGNANT MELANOMA | 4 0.04 60.80 MALIGNANT NEOPLASM PROGRESSION | 7 0.07 60.87 MALIGNANT PLEURAL EFFUSION | 2 0.02 60.89 MALNUTRITION | 3 0.03 60.92 MANIA | 7 0.07 60.99 MANTLE CELL LYMPHOMA | 1 0.01 61.00 MARFAN'S SYNDROME | 1 0.01 61.01 MASS | 6 0.06 61.07 MASS EXCISION | 1 0.01 61.08 MASTECTOMY | 1 0.01 61.09 MAXILLOFACIAL OPERATION | 1 0.01 61.10 MEAN CELL HAEMOGLOBIN INCREASED | 1 0.01 61.11 MECHANICAL VENTILATION | 1 0.01 61.12 MECONIUM INCREASED | 1 0.01 61.13 MEDICAL DEVICE COMPLICATION | 2 0.02 61.15 MEDICAL DEVICE IMPLANTATION | 1 0.01 61.16 MEDICATION ERROR | 10 0.10 61.26 MEGAKARYOCYTES INCREASED | 1 0.01 61.27 MELAENA | 4 0.04 61.31 MEMORY IMPAIRMENT | 15 0.15 61.46 MENINGIOMA SURGERY | 1 0.01 61.47 MENOPAUSAL SYMPTOMS | 1 0.01 61.48 MENORRHAGIA | 1 0.01 61.49 MENSTRUAL DISORDER | 3 0.03 61.52 MENSTRUATION DELAYED | 1 0.01 61.53 MENSTRUATION IRREGULAR | 1 0.01 61.54 MENTAL DISORDER | 8 0.08 61.62 MENTAL IMPAIRMENT | 8 0.08 61.70 MENTAL STATUS CHANGES | 6 0.06 61.76 MESENTERIC VEIN THROMBOSIS | 1 0.01 61.77 METABOLIC ACIDOSIS | 3 0.03 61.80 METABOLIC DISORDER | 1 0.01 61.81 METABOLIC SYNDROME | 1 0.01 61.82 METASTASES TO BONE | 7 0.07 61.89 METASTASES TO LIVER | 4 0.04 61.93 METASTASES TO LUNG | 2 0.02 61.95 METASTASES TO LYMPH NODES | 2 0.02 61.97 METASTASES TO NERVOUS SYSTEM | 1 0.01 61.98 METASTASES TO SPINE | 1 0.01 61.99 METASTASIS | 1 0.01 62.00 METASTATIC NEOPLASM | 3 0.03 62.03 METHICILLIN-RESISTANT STAPHYLOCOCCAL .. | 1 0.01 62.04 METRORRHAGIA | 4 0.04 62.08 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA | 1 0.01 62.09 MICROANGIOPATHY | 2 0.02 62.11 MICTURITION URGENCY | 2 0.02 62.13 MIDDLE INSOMNIA | 18 0.18 62.31 MIGRAINE | 9 0.09 62.40 MIGRAINE WITH AURA | 2 0.02 62.42 MILLER FISHER SYNDROME | 1 0.01 62.43 MITRAL VALVE INCOMPETENCE | 2 0.02 62.45 MOBILITY DECREASED | 6 0.06 62.51 MONARTHRITIS | 2 0.02 62.53 MONOCLONAL IMMUNOGLOBULIN PRESENT | 1 0.01 62.54 MOOD ALTERED | 23 0.23 62.77 MOOD SWINGS | 18 0.18 62.95 MOTOR DYSFUNCTION | 2 0.02 62.97 MOUTH HAEMORRHAGE | 2 0.02 62.99 MOUTH ULCERATION | 7 0.07 63.06 MOVEMENT DISORDER | 4 0.04 63.10 MUCOCUTANEOUS RASH | 1 0.01 63.11 MUCOSAL DRYNESS | 1 0.01 63.12 MUCOSAL EROSION | 2 0.02 63.14 MUCOSAL INFLAMMATION | 11 0.11 63.25 MUCOUS MEMBRANE DISORDER | 2 0.02 63.27 MUCOUS STOOLS | 1 0.01 63.28 MULTI-ORGAN DISORDER | 2 0.02 63.30 MULTI-ORGAN FAILURE | 7 0.07 63.37 MULTIPLE ALLERGIES | 1 0.01 63.38 MULTIPLE CHEMICAL SENSITIVITY | 1 0.01 63.39 MULTIPLE CONGENITAL ABNORMALITIES | 2 0.02 63.41 MULTIPLE DRUG OVERDOSE | 4 0.04 63.45 MULTIPLE DRUG OVERDOSE INTENTIONAL | 18 0.18 63.63 MULTIPLE FRACTURES | 1 0.01 63.64 MULTIPLE INJURIES | 1 0.01 63.65 MULTIPLE MYELOMA | 2 0.02 63.67 MULTIPLE SCLEROSIS | 8 0.08 63.75 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 63.76 MUSCLE ABSCESS | 1 0.01 63.77 MUSCLE ATROPHY | 1 0.01 63.78 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 63.79 MUSCLE DISORDER | 2 0.02 63.81 MUSCLE HAEMORRHAGE | 2 0.02 63.83 MUSCLE INJURY | 1 0.01 63.84 MUSCLE SPASMS | 58 0.58 64.42 MUSCLE SPASTICITY | 1 0.01 64.43 MUSCLE STRAIN | 2 0.02 64.45 MUSCLE TIGHTNESS | 5 0.05 64.50 MUSCLE TWITCHING | 4 0.04 64.54 MUSCULAR DYSTROPHY | 1 0.01 64.55 MUSCULAR WEAKNESS | 13 0.13 64.68 MUSCULOSKELETAL CHEST PAIN | 5 0.05 64.73 MUSCULOSKELETAL DISCOMFORT | 3 0.03 64.76 MUSCULOSKELETAL DISORDER | 1 0.01 64.77 MUSCULOSKELETAL PAIN | 15 0.15 64.92 MUSCULOSKELETAL STIFFNESS | 14 0.14 65.06 MYALGIA | 48 0.48 65.54 MYASTHENIA GRAVIS | 1 0.01 65.55 MYCOSIS FUNGOIDES | 1 0.01 65.56 MYDRIASIS | 3 0.03 65.59 MYELITIS | 1 0.01 65.60 MYELODYSPLASTIC SYNDROME | 2 0.02 65.62 MYOCARDIAL INFARCTION | 59 0.59 66.21 MYOCARDIAL ISCHAEMIA | 3 0.03 66.24 MYOCARDITIS | 2 0.02 66.26 MYOCLONUS | 4 0.04 66.30 MYOGLOBIN BLOOD INCREASED | 1 0.01 66.31 MYOPATHY | 3 0.03 66.34 MYOPIA | 1 0.01 66.35 MYOTONIA | 1 0.01 66.36 NAIL DISCOLOURATION | 1 0.01 66.37 NAIL DISORDER | 5 0.05 66.42 NAIL GROWTH ABNORMAL | 2 0.02 66.44 NARCOLEPSY | 1 0.01 66.45 NASAL CONGESTION | 3 0.03 66.48 NASAL DRYNESS | 2 0.02 66.50 NASAL MUCOSAL DISORDER | 2 0.02 66.52 NASAL OEDEMA | 1 0.01 66.53 NASAL SEPTUM ULCERATION | 1 0.01 66.54 NASAL ULCER | 1 0.01 66.55 NASOPHARYNGITIS | 2 0.02 66.57 NAUSEA | 119 1.19 67.76 NECK MASS | 1 0.01 67.77 NECK PAIN | 12 0.12 67.89 NECROBIOSIS | 1 0.01 67.90 NECROSIS | 4 0.04 67.94 NEOPLASM | 2 0.02 67.96 NEOPLASM MALIGNANT | 10 0.10 68.06 NEOPLASM PROGRESSION | 1 0.01 68.07 NEOPLASM RECURRENCE | 2 0.02 68.09 NEOPLASM SKIN | 1 0.01 68.10 NEPHRECTOMY | 1 0.01 68.11 NEPHRITIS INTERSTITIAL | 3 0.03 68.14 NEPHROGENIC SYSTEMIC FIBROSIS | 1 0.01 68.15 NEPHROLITHIASIS | 12 0.12 68.27 NEPHROPATHY | 3 0.03 68.30 NEPHROPATHY TOXIC | 4 0.04 68.34 NEPHROSCLEROSIS | 1 0.01 68.35 NEPHROSTOMY | 1 0.01 68.36 NEPHROTIC SYNDROME | 2 0.02 68.38 NERVE INJURY | 4 0.04 68.42 NERVE ROOT COMPRESSION | 1 0.01 68.43 NERVOUS SYSTEM DISORDER | 9 0.09 68.52 NERVOUSNESS | 12 0.12 68.64 NEURALGIA | 4 0.04 68.68 NEUROENDOCRINE TUMOUR | 1 0.01 68.69 NEUROLOGICAL SYMPTOM | 1 0.01 68.70 NEUROMA | 1 0.01 68.71 NEUROPATHIC ARTHROPATHY | 1 0.01 68.72 NEUROPATHY | 5 0.05 68.77 NEUROPATHY PERIPHERAL | 8 0.08 68.85 NEUROTOXICITY | 2 0.02 68.87 NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 68.88 NEUTROPENIA | 23 0.23 69.11 NEUTROPENIC SEPSIS | 2 0.02 69.13 NEUTROPHIL COUNT ABNORMAL | 1 0.01 69.14 NEUTROPHIL COUNT DECREASED | 1 0.01 69.15 NEUTROPHIL PERCENTAGE DECREASED | 1 0.01 69.16 NIGHT SWEATS | 12 0.12 69.28 NIGHTMARE | 11 0.11 69.39 NO ADVERSE REACTION | 6 0.06 69.45 NO THERAPEUTIC RESPONSE | 3 0.03 69.48 NOCTURIA | 2 0.02 69.50 NODULE | 4 0.04 69.54 NODULE ON EXTREMITY | 1 0.01 69.55 NON-CARDIAC CHEST PAIN | 1 0.01 69.56 NON-HODGKIN'S LYMPHOMA | 1 0.01 69.57 NORMAL NEWBORN | 2 0.02 69.59 NORMOCHROMIC NORMOCYTIC ANAEMIA | 1 0.01 69.60 NUCHAL RIGIDITY | 1 0.01 69.61 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 69.62 OBSESSIVE THOUGHTS | 2 0.02 69.64 OBSESSIVE-COMPULSIVE DISORDER | 6 0.06 69.70 OBSTRUCTED LABOUR | 1 0.01 69.71 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 69.72 OCCULT BLOOD POSITIVE | 2 0.02 69.74 OCULAR DISCOMFORT | 1 0.01 69.75 OCULAR HYPERAEMIA | 4 0.04 69.79 OCULAR ICTERUS | 1 0.01 69.80 OCULAR VASCULAR DISORDER | 1 0.01 69.81 OCULOGYRIC CRISIS | 1 0.01 69.82 ODYNOPHAGIA | 6 0.06 69.88 OEDEMA | 11 0.11 69.99 OEDEMA MOUTH | 2 0.02 70.01 OEDEMA PERIPHERAL | 55 0.55 70.56 OESOPHAGEAL CANDIDIASIS | 1 0.01 70.57 OESOPHAGEAL CARCINOMA | 1 0.01 70.58 OESOPHAGEAL HAEMORRHAGE | 1 0.01 70.59 OESOPHAGEAL PERFORATION | 1 0.01 70.60 OESOPHAGEAL RUPTURE | 1 0.01 70.61 OESOPHAGEAL ULCER | 1 0.01 70.62 OESOPHAGITIS | 2 0.02 70.64 OFF LABEL USE | 7 0.07 70.71 OLIGURIA | 2 0.02 70.73 ONYCHOCLASIS | 7 0.07 70.80 ONYCHOMADESIS | 2 0.02 70.82 OOPHORECTOMY | 1 0.01 70.83 OPEN FRACTURE | 1 0.01 70.84 OPEN WOUND | 1 0.01 70.85 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 70.86 OPTIC NERVE INFARCTION | 1 0.01 70.87 OPTIC NEURITIS | 1 0.01 70.88 ORAL CANDIDIASIS | 1 0.01 70.89 ORAL DISCOMFORT | 3 0.03 70.92 ORAL DISORDER | 1 0.01 70.93 ORAL FUNGAL INFECTION | 1 0.01 70.94 ORAL HERPES | 1 0.01 70.95 ORAL INFECTION | 2 0.02 70.97 ORAL INTAKE REDUCED | 5 0.05 71.02 ORAL MUCOSAL BLISTERING | 3 0.03 71.05 ORAL PAIN | 7 0.07 71.12 ORAL PRURITUS | 2 0.02 71.14 ORBITAL OEDEMA | 1 0.01 71.15 ORCHITIS | 1 0.01 71.16 ORGAN FAILURE | 10 0.10 71.26 ORTHOPNOEA | 2 0.02 71.28 ORTHOSTATIC HYPOTENSION | 6 0.06 71.34 OSTEOARTHRITIS | 8 0.08 71.42 OSTEOLYSIS | 1 0.01 71.43 OSTEOMYELITIS | 4 0.04 71.47 OSTEOMYELITIS CHRONIC | 1 0.01 71.48 OSTEONECROSIS | 31 0.31 71.79 OSTEOPENIA | 12 0.12 71.91 OSTEOPOROSIS | 24 0.24 72.15 OTITIS MEDIA | 2 0.02 72.17 OVARIAN CANCER | 1 0.01 72.18 OVARIAN CANCER METASTATIC | 2 0.02 72.20 OVARIAN CYST | 4 0.04 72.24 OVARIAN DISORDER | 2 0.02 72.26 OVARIAN ENLARGEMENT | 1 0.01 72.27 OVARIAN GERM CELL CANCER STAGE III | 1 0.01 72.28 OVARIAN MASS | 2 0.02 72.30 OVARIAN OPERATION | 1 0.01 72.31 OVERDOSE | 25 0.25 72.56 OVERWEIGHT | 1 0.01 72.57 OXYGEN SATURATION DECREASED | 9 0.09 72.66 PAIN | 69 0.69 73.35 PAIN IN EXTREMITY | 64 0.64 73.99 PAIN IN JAW | 11 0.11 74.10 PAIN OF SKIN | 1 0.01 74.11 PAINFUL RESPIRATION | 1 0.01 74.12 PALINDROMIC RHEUMATISM | 1 0.01 74.13 PALLOR | 4 0.04 74.17 PALMAR ERYTHEMA | 1 0.01 74.18 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 4 0.04 74.22 PALPITATIONS | 15 0.15 74.37 PANCREAS INFECTION | 1 0.01 74.38 PANCREATIC CARCINOMA | 3 0.03 74.41 PANCREATIC DISORDER | 3 0.03 74.44 PANCREATIC ENZYMES INCREASED | 1 0.01 74.45 PANCREATIC INSUFFICIENCY | 1 0.01 74.46 PANCREATIC NEOPLASM | 1 0.01 74.47 PANCREATITIS | 12 0.12 74.59 PANCREATITIS ACUTE | 8 0.08 74.67 PANCYTOPENIA | 15 0.15 74.82 PANIC ATTACK | 7 0.07 74.89 PANIC DISORDER | 1 0.01 74.90 PANIC REACTION | 2 0.02 74.92 PAPILLARY THYROID CANCER | 1 0.01 74.93 PAPILLOEDEMA | 1 0.01 74.94 PARADOXICAL DRUG REACTION | 1 0.01 74.95 PARAESTHESIA | 38 0.38 75.33 PARAESTHESIA ORAL | 4 0.04 75.37 PARALYSIS | 3 0.03 75.40 PARANEOPLASTIC SYNDROME | 1 0.01 75.41 PARANOIA | 6 0.06 75.47 PARAPARESIS | 1 0.01 75.48 PARESIS | 1 0.01 75.49 PARKINSON'S DISEASE | 1 0.01 75.50 PARKINSONISM | 7 0.07 75.57 PAROSMIA | 4 0.04 75.61 PATENT DUCTUS ARTERIOSUS | 5 0.05 75.66 PATHOLOGICAL GAMBLING | 4 0.04 75.70 PCO2 DECREASED | 3 0.03 75.73 PELIOSIS HEPATIS | 2 0.02 75.75 PELVIC FRACTURE | 5 0.05 75.80 PELVIC INFLAMMATORY DISEASE | 1 0.01 75.81 PELVIC PAIN | 7 0.07 75.88 PELVIC VENOUS THROMBOSIS | 3 0.03 75.91 PENIS CARCINOMA | 1 0.01 75.92 PEPTIC ULCER | 1 0.01 75.93 PERFORMANCE STATUS DECREASED | 3 0.03 75.96 PERIARTHRITIS | 1 0.01 75.97 PERICARDIAL EFFUSION | 6 0.06 76.03 PERICARDITIS | 2 0.02 76.05 PERICORONITIS | 1 0.01 76.06 PERINEPHRIC COLLECTION | 1 0.01 76.07 PERIODONTAL DISEASE | 3 0.03 76.10 PERIODONTITIS | 1 0.01 76.11 PERIORBITAL HAEMATOMA | 2 0.02 76.13 PERIORBITAL OEDEMA | 2 0.02 76.15 PERIPHERAL COLDNESS | 3 0.03 76.18 PERIPHERAL ISCHAEMIA | 1 0.01 76.19 PERIPHERAL VASCULAR DISORDER | 4 0.04 76.23 PERIRECTAL ABSCESS | 2 0.02 76.25 PERITONEAL ADHESIONS DIVISION | 1 0.01 76.26 PERITONEAL HAEMORRHAGE | 1 0.01 76.27 PERITONSILLAR ABSCESS | 1 0.01 76.28 PERONEAL NERVE PALSY | 1 0.01 76.29 PERSONALITY CHANGE | 5 0.05 76.34 PETECHIAE | 3 0.03 76.37 PETIT MAL EPILEPSY | 1 0.01 76.38 PH URINE INCREASED | 1 0.01 76.39 PHARMACEUTICAL PRODUCT COMPLAINT | 24 0.24 76.63 PHARMACEUTICAL PRODUCT COUNTERFEIT | 4 0.04 76.67 PHARYNGEAL DISORDER | 3 0.03 76.70 PHARYNGEAL HAEMORRHAGE | 1 0.01 76.71 PHARYNGEAL OEDEMA | 6 0.06 76.77 PHARYNGITIS | 2 0.02 76.79 PHARYNGITIS STREPTOCOCCAL | 1 0.01 76.80 PHARYNGOLARYNGEAL PAIN | 34 0.34 77.14 PHLEBITIS | 1 0.01 77.15 PHOTOPHOBIA | 8 0.08 77.23 PHOTOPSIA | 2 0.02 77.25 PHOTOSENSITIVITY REACTION | 4 0.04 77.29 PHYSICAL ASSAULT | 2 0.02 77.31 PHYSICAL EXAMINATION | 1 0.01 77.32 PIGMENTATION DISORDER | 1 0.01 77.33 PILOERECTION | 1 0.01 77.34 PITTING OEDEMA | 1 0.01 77.35 PITUITARY TUMOUR | 1 0.01 77.36 PITUITARY TUMOUR BENIGN | 1 0.01 77.37 PLACENTAL DISORDER | 2 0.02 77.39 PLACENTAL INSUFFICIENCY | 1 0.01 77.40 PLANTAR FASCIITIS | 1 0.01 77.41 PLATELET COUNT ABNORMAL | 1 0.01 77.42 PLATELET COUNT DECREASED | 20 0.20 77.62 PLATELET COUNT INCREASED | 3 0.03 77.65 PLATELET DISORDER | 1 0.01 77.66 PLEURAL EFFUSION | 10 0.10 77.76 PLEURAL HAEMORRHAGE | 1 0.01 77.77 PLEURISY | 3 0.03 77.80 PLEURITIC PAIN | 2 0.02 77.82 PLEUROTHOTONUS | 2 0.02 77.84 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 77.85 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 77.87 PNEUMONIA | 41 0.41 78.28 PNEUMONIA ASPIRATION | 6 0.06 78.34 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 78.35 PNEUMONIA KLEBSIELLA | 1 0.01 78.36 PNEUMONIA LEGIONELLA | 1 0.01 78.37 PNEUMONIA MYCOPLASMAL | 1 0.01 78.38 PNEUMONIA PNEUMOCOCCAL | 1 0.01 78.39 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.40 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 78.41 PNEUMONITIS | 4 0.04 78.45 PNEUMOPERITONEUM | 1 0.01 78.46 PNEUMOTHORAX | 1 0.01 78.47 PO2 DECREASED | 2 0.02 78.49 POISONING | 28 0.28 78.77 POLLAKIURIA | 5 0.05 78.82 POLYARTHRITIS | 1 0.01 78.83 POLYCYSTIC OVARIES | 1 0.01 78.84 POLYCYTHAEMIA | 2 0.02 78.86 POLYDIPSIA | 2 0.02 78.88 POLYMYALGIA RHEUMATICA | 1 0.01 78.89 POLYNEUROPATHY | 1 0.01 78.90 POLYURIA | 1 0.01 78.91 POOR PERIPHERAL CIRCULATION | 1 0.01 78.92 POOR QUALITY DRUG ADMINISTERED | 5 0.05 78.97 POOR QUALITY SLEEP | 4 0.04 79.01 PORIOMANIA | 1 0.01 79.02 PORPHYRIA | 1 0.01 79.03 PORTAL HYPERTENSION | 2 0.02 79.05 PORTAL VEIN THROMBOSIS | 2 0.02 79.07 POST GASTRIC SURGERY SYNDROME | 1 0.01 79.08 POST POLIO SYNDROME | 1 0.01 79.09 POST PROCEDURAL COMPLICATION | 3 0.03 79.12 POST PROCEDURAL DISCHARGE | 1 0.01 79.13 POST PROCEDURAL DISCOMFORT | 1 0.01 79.14 POST PROCEDURAL HAEMATOMA | 3 0.03 79.17 POST PROCEDURAL HAEMORRHAGE | 2 0.02 79.19 POST STREPTOCOCCAL GLOMERULONEPHRITIS | 1 0.01 79.20 POSTICTAL HEADACHE | 1 0.01 79.21 POSTICTAL STATE | 1 0.01 79.22 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 79.23 POSTNASAL DRIP | 1 0.01 79.24 POSTOPERATIVE WOUND INFECTION | 1 0.01 79.25 POSTRENAL FAILURE | 1 0.01 79.26 POSTURE ABNORMAL | 3 0.03 79.29 POUCHITIS | 1 0.01 79.30 PRE-ECLAMPSIA | 1 0.01 79.31 PREGNANCY | 8 0.08 79.39 PREGNANCY INDUCED HYPERTENSION | 2 0.02 79.41 PREMATURE BABY | 9 0.09 79.50 PREMATURE LABOUR | 3 0.03 79.53 PREMATURE RUPTURE OF MEMBRANES | 2 0.02 79.55 PRESYNCOPE | 5 0.05 79.60 PRIMARY SEQUESTRUM | 3 0.03 79.63 PROCEDURAL COMPLICATION | 1 0.01 79.64 PROCEDURAL PAIN | 2 0.02 79.66 PROCTALGIA | 2 0.02 79.68 PROCTITIS | 1 0.01 79.69 PROCTITIS ULCERATIVE | 1 0.01 79.70 PRODUCTIVE COUGH | 4 0.04 79.74 PROSTATE CANCER | 5 0.05 79.79 PROSTATE EXAMINATION ABNORMAL | 1 0.01 79.80 PROSTATIC DISORDER | 1 0.01 79.81 PROSTATIC HAEMORRHAGE | 1 0.01 79.82 PROSTHESIS IMPLANTATION | 1 0.01 79.83 PROTEIN TOTAL DECREASED | 1 0.01 79.84 PROTEIN URINE PRESENT | 2 0.02 79.86 PROTEINURIA | 5 0.05 79.91 PROTHROMBIN TIME ABNORMAL | 1 0.01 79.92 PROTHROMBIN TIME PROLONGED | 2 0.02 79.94 PRURITUS | 39 0.39 80.33 PRURITUS GENERALISED | 2 0.02 80.35 PSEUDARTHROSIS | 1 0.01 80.36 PSEUDOMONAS INFECTION | 1 0.01 80.37 PSEUDOPOLYP | 1 0.01 80.38 PSORIASIS | 4 0.04 80.42 PSYCHIATRIC SYMPTOM | 3 0.03 80.45 PSYCHOMOTOR HYPERACTIVITY | 5 0.05 80.50 PSYCHOSIS POSTOPERATIVE | 1 0.01 80.51 PSYCHOSOMATIC DISEASE | 1 0.01 80.52 PSYCHOTIC DISORDER | 17 0.17 80.69 PULMONARY ARTERIAL WEDGE PRESSURE INC.. | 1 0.01 80.70 PULMONARY CONGESTION | 1 0.01 80.71 PULMONARY EMBOLISM | 33 0.33 81.04 PULMONARY FIBROSIS | 1 0.01 81.05 PULMONARY GRANULOMA | 1 0.01 81.06 PULMONARY HAEMORRHAGE | 1 0.01 81.07 PULMONARY HYPERTENSION | 6 0.06 81.13 PULMONARY INFARCTION | 2 0.02 81.15 PULMONARY MASS | 1 0.01 81.16 PULMONARY OEDEMA | 10 0.10 81.26 PULMONARY OEDEMA NEONATAL | 1 0.01 81.27 PULMONARY SEPSIS | 1 0.01 81.28 PULMONARY THROMBOSIS | 1 0.01 81.29 PULMONARY TUBERCULOSIS | 2 0.02 81.31 PULMONARY VALVE INCOMPETENCE | 1 0.01 81.32 PULMONARY VALVE STENOSIS | 1 0.01 81.33 PULSE ABSENT | 2 0.02 81.35 PUPILLARY REFLEX IMPAIRED | 1 0.01 81.36 PURPURA | 4 0.04 81.40 PURULENT DISCHARGE | 2 0.02 81.42 PUSTULAR PSORIASIS | 1 0.01 81.43 PYLORIC STENOSIS | 1 0.01 81.44 PYODERMA GANGRENOSUM | 1 0.01 81.45 PYREXIA | 73 0.73 82.18 PYURIA | 1 0.01 82.19 RADIATION INJURY | 1 0.01 82.20 RADICULOPATHY | 1 0.01 82.21 RADIOTHERAPY | 1 0.01 82.22 RASH | 46 0.46 82.68 RASH ERYTHEMATOUS | 12 0.12 82.80 RASH GENERALISED | 11 0.11 82.91 RASH MACULAR | 7 0.07 82.98 RASH MACULO-PAPULAR | 3 0.03 83.01 RASH PAPULAR | 1 0.01 83.02 RASH PRURITIC | 7 0.07 83.09 RASH PUSTULAR | 3 0.03 83.12 RASH SCARLATINIFORM | 1 0.01 83.13 RASH VESICULAR | 3 0.03 83.16 RAYNAUD'S PHENOMENON | 3 0.03 83.19 RECTAL ABSCESS | 1 0.01 83.20 RECTAL HAEMORRHAGE | 6 0.06 83.26 RECURRENT CANCER | 1 0.01 83.27 RED BLOOD CELL COUNT DECREASED | 12 0.12 83.39 RED BLOOD CELL COUNT INCREASED | 1 0.01 83.40 RED BLOOD CELL SEDIMENTATION RATE INC.. | 2 0.02 83.42 RED BLOOD CELLS URINE POSITIVE | 1 0.01 83.43 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 83.44 REFLUX OESOPHAGITIS | 4 0.04 83.48 REFUSAL OF TREATMENT BY PATIENT | 1 0.01 83.49 RENAL ARTERY STENT PLACEMENT | 1 0.01 83.50 RENAL ATROPHY | 1 0.01 83.51 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 2 0.02 83.53 RENAL CYST | 3 0.03 83.56 RENAL DISORDER | 1 0.01 83.57 RENAL FAILURE | 38 0.38 83.95 RENAL FAILURE ACUTE | 37 0.37 84.32 RENAL FAILURE CHRONIC | 6 0.06 84.38 RENAL FUNCTION TEST ABNORMAL | 1 0.01 84.39 RENAL IMPAIRMENT | 13 0.13 84.52 RENAL INJURY | 1 0.01 84.53 RENAL MASS | 1 0.01 84.54 RENAL PAIN | 1 0.01 84.55 RENAL TUBULAR DISORDER | 1 0.01 84.56 RENAL TUBULAR NECROSIS | 5 0.05 84.61 RENAL VESSEL DISORDER | 1 0.01 84.62 RESORPTION BONE INCREASED | 2 0.02 84.64 RESPIRATORY ACIDOSIS | 1 0.01 84.65 RESPIRATORY ARREST | 5 0.05 84.70 RESPIRATORY DEPRESSION | 2 0.02 84.72 RESPIRATORY DISORDER | 3 0.03 84.75 RESPIRATORY DISTRESS | 4 0.04 84.79 RESPIRATORY FAILURE | 21 0.21 85.00 RESPIRATORY RATE DECREASED | 2 0.02 85.02 RESPIRATORY RATE INCREASED | 1 0.01 85.03 RESPIRATORY TRACT INFECTION | 1 0.01 85.04 RESTLESS LEGS SYNDROME | 2 0.02 85.06 RESTLESSNESS | 13 0.13 85.19 RESUSCITATION | 2 0.02 85.21 RETCHING | 7 0.07 85.28 RETINAL ARTERY OCCLUSION | 1 0.01 85.29 RETINAL DETACHMENT | 2 0.02 85.31 RETINAL HAEMORRHAGE | 4 0.04 85.35 RETINAL VASCULAR DISORDER | 1 0.01 85.36 RETINITIS PIGMENTOSA | 1 0.01 85.37 RETINOPATHY | 2 0.02 85.39 RETROPERITONEAL FIBROSIS | 1 0.01 85.40 RETROPERITONEAL HAEMORRHAGE | 1 0.01 85.41 RHABDOMYOLYSIS | 19 0.19 85.60 RHEUMATOID ARTHRITIS | 7 0.07 85.67 RHINORRHOEA | 1 0.01 85.68 RIB FRACTURE | 7 0.07 85.75 RIGHT VENTRICULAR FAILURE | 1 0.01 85.76 RIGHT VENTRICULAR HYPERTROPHY | 1 0.01 85.77 ROAD TRAFFIC ACCIDENT | 21 0.21 85.98 ROTATOR CUFF SYNDROME | 3 0.03 86.01 SARCOIDOSIS | 2 0.02 86.03 SCAB | 1 0.01 86.04 SCAN ABDOMEN ABNORMAL | 1 0.01 86.05 SCAR | 3 0.03 86.08 SCHIZOAFFECTIVE DISORDER | 1 0.01 86.09 SCHIZOPHRENIA | 2 0.02 86.11 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 86.12 SCIATICA | 3 0.03 86.15 SCLERODERMA | 1 0.01 86.16 SCLEROSING ENCAPSULATING PERITONITIS | 1 0.01 86.17 SCOLIOSIS | 1 0.01 86.18 SCREAMING | 1 0.01 86.19 SEDATION | 2 0.02 86.21 SELF INJURIOUS BEHAVIOUR | 1 0.01 86.22 SELF MUTILATION | 2 0.02 86.24 SELF-INJURIOUS IDEATION | 4 0.04 86.28 SELF-MEDICATION | 2 0.02 86.30 SEMINOMA | 1 0.01 86.31 SENSATION OF FOREIGN BODY | 1 0.01 86.32 SENSATION OF HEAVINESS | 1 0.01 86.33 SENSE OF OPPRESSION | 1 0.01 86.34 SENSITIVITY OF TEETH | 2 0.02 86.36 SENSORY DISTURBANCE | 4 0.04 86.40 SENSORY LOSS | 2 0.02 86.42 SEPSIS | 20 0.20 86.62 SEPTIC SHOCK | 5 0.05 86.67 SEQUESTRECTOMY | 1 0.01 86.68 SEROTONIN SYNDROME | 4 0.04 86.72 SERUM FERRITIN INCREASED | 1 0.01 86.73 SERUM SICKNESS | 2 0.02 86.75 SEXUAL DYSFUNCTION | 2 0.02 86.77 SHARED PSYCHOTIC DISORDER | 1 0.01 86.78 SHIFT TO THE LEFT | 1 0.01 86.79 SHOCK | 7 0.07 86.86 SICKLE CELL ANAEMIA | 1 0.01 86.87 SILENT MYOCARDIAL INFARCTION | 3 0.03 86.90 SIMPLE PARTIAL SEIZURES | 1 0.01 86.91 SINUS ARRHYTHMIA | 1 0.01 86.92 SINUS BRADYCARDIA | 2 0.02 86.94 SINUS CONGESTION | 1 0.01 86.95 SINUS DISORDER | 4 0.04 86.99 SINUS TACHYCARDIA | 5 0.05 87.04 SINUSITIS | 9 0.09 87.13 SJOGREN'S SYNDROME | 1 0.01 87.14 SKIN BURNING SENSATION | 1 0.01 87.15 SKIN CANCER | 4 0.04 87.19 SKIN CHAPPED | 1 0.01 87.20 SKIN DISCOLOURATION | 5 0.05 87.25 SKIN DISORDER | 12 0.12 87.37 SKIN EXFOLIATION | 6 0.06 87.43 SKIN HYPERPIGMENTATION | 1 0.01 87.44 SKIN INDURATION | 1 0.01 87.45 SKIN INFECTION | 1 0.01 87.46 SKIN IRRITATION | 4 0.04 87.50 SKIN LACERATION | 5 0.05 87.55 SKIN LESION | 4 0.04 87.59 SKIN NECROSIS | 2 0.02 87.61 SKIN NEOPLASM EXCISION | 1 0.01 87.62 SKIN NODULE | 2 0.02 87.64 SKIN ODOUR ABNORMAL | 1 0.01 87.65 SKIN REACTION | 5 0.05 87.70 SKIN TOXICITY | 1 0.01 87.71 SKIN ULCER | 7 0.07 87.78 SKIN WRINKLING | 2 0.02 87.80 SLEEP ATTACKS | 1 0.01 87.81 SLEEP DISORDER | 10 0.10 87.91 SLEEP TALKING | 1 0.01 87.92 SLEEP TERROR | 1 0.01 87.93 SLUGGISHNESS | 2 0.02 87.95 SMALL FOR DATES BABY | 1 0.01 87.96 SMALL INTESTINAL OBSTRUCTION | 4 0.04 88.00 SMALL INTESTINAL STENOSIS | 1 0.01 88.01 SMALL INTESTINE OPERATION | 1 0.01 88.02 SMEAR CERVIX ABNORMAL | 2 0.02 88.04 SMOKER | 3 0.03 88.07 SNEEZING | 1 0.01 88.08 SNORING | 1 0.01 88.09 SOCIAL AVOIDANT BEHAVIOUR | 2 0.02 88.11 SOFT TISSUE INFLAMMATION | 1 0.01 88.12 SOMNAMBULISM | 4 0.04 88.16 SOMNOLENCE | 45 0.45 88.61 SOMNOLENCE NEONATAL | 1 0.01 88.62 SPEECH DISORDER | 7 0.07 88.69 SPHINCTER OF ODDI DYSFUNCTION | 1 0.01 88.70 SPINAL COLUMN STENOSIS | 2 0.02 88.72 SPINAL CORD DISORDER | 2 0.02 88.74 SPINAL DECOMPRESSION | 1 0.01 88.75 SPINAL DISORDER | 1 0.01 88.76 SPINAL FRACTURE | 3 0.03 88.79 SPINAL OPERATION | 1 0.01 88.80 SPINAL OSTEOARTHRITIS | 1 0.01 88.81 SPLENIC GRANULOMA | 1 0.01 88.82 SPLENIC INFARCTION | 1 0.01 88.83 SPLENOMEGALY | 3 0.03 88.86 SPONDYLITIS | 1 0.01 88.87 SPONDYLOLISTHESIS | 1 0.01 88.88 SPUTUM DECREASED | 1 0.01 88.89 SQUAMOUS CELL CARCINOMA | 3 0.03 88.92 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 88.93 STAPHYLOCOCCAL INFECTION | 4 0.04 88.97 STAPHYLOCOCCAL SEPSIS | 1 0.01 88.98 STATUS ASTHMATICUS | 3 0.03 89.01 STATUS EPILEPTICUS | 2 0.02 89.03 STEM CELL TRANSPLANT | 2 0.02 89.05 STENT PLACEMENT | 3 0.03 89.08 STEVENS-JOHNSON SYNDROME | 19 0.19 89.27 STILLBIRTH | 1 0.01 89.28 STOMACH DISCOMFORT | 16 0.16 89.44 STOMATITIS | 15 0.15 89.59 STOMATITIS NECROTISING | 1 0.01 89.60 STRABISMUS | 1 0.01 89.61 STREPTOCOCCAL IDENTIFICATION TEST POS.. | 1 0.01 89.62 STRESS | 4 0.04 89.66 STRESS CARDIOMYOPATHY | 1 0.01 89.67 STRESS FRACTURE | 1 0.01 89.68 STRESS ULCER | 1 0.01 89.69 STRESS URINARY INCONTINENCE | 1 0.01 89.70 STRIDOR | 3 0.03 89.73 SUBARACHNOID HAEMORRHAGE | 2 0.02 89.75 SUBCUTANEOUS ABSCESS | 1 0.01 89.76 SUBCUTANEOUS EMPHYSEMA | 1 0.01 89.77 SUBCUTANEOUS NODULE | 1 0.01 89.78 SUBDURAL HAEMATOMA | 1 0.01 89.79 SUBSTANCE ABUSE | 3 0.03 89.82 SUCROSE INTOLERANCE | 1 0.01 89.83 SUDDEN DEATH | 4 0.04 89.87 SUDDEN HEARING LOSS | 1 0.01 89.88 SUDDEN INFANT DEATH SYNDROME | 1 0.01 89.89 SUDDEN ONSET OF SLEEP | 1 0.01 89.90 SUFFOCATION FEELING | 2 0.02 89.92 SUICIDAL BEHAVIOUR | 1 0.01 89.93 SUICIDAL IDEATION | 27 0.27 90.20 SUICIDE ATTEMPT | 21 0.21 90.41 SUNBURN | 1 0.01 90.42 SUPERINFECTION | 1 0.01 90.43 SUPPRESSED LACTATION | 1 0.01 90.44 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 90.45 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 90.46 SURGERY | 16 0.16 90.62 SWELLING | 13 0.13 90.75 SWELLING FACE | 13 0.13 90.88 SWOLLEN TONGUE | 9 0.09 90.97 SYNCOPE | 16 0.16 91.13 SYSTEMIC CANDIDA | 2 0.02 91.15 SYSTEMIC LUPUS ERYTHEMATOSUS | 1 0.01 91.16 TACHYCARDIA | 15 0.15 91.31 TAKAYASU'S ARTERITIS | 1 0.01 91.32 TARDIVE DYSKINESIA | 2 0.02 91.34 TEETH BRITTLE | 1 0.01 91.35 TEMPERATURE INTOLERANCE | 1 0.01 91.36 TEMPORAL LOBE EPILEPSY | 1 0.01 91.37 TENDERNESS | 1 0.01 91.38 TENDON DISORDER | 1 0.01 91.39 TENDON RUPTURE | 4 0.04 91.43 TENDONITIS | 3 0.03 91.46 TESTICULAR MASS | 2 0.02 91.48 TESTICULAR PAIN | 1 0.01 91.49 TESTICULAR SWELLING | 1 0.01 91.50 TETANY | 1 0.01 91.51 THERAPEUTIC RESPONSE DECREASED | 4 0.04 91.55 THERAPEUTIC RESPONSE UNEXPECTED | 6 0.06 91.61 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 1 0.01 91.62 THERAPY CESSATION | 1 0.01 91.63 THERAPY REGIMEN CHANGED | 1 0.01 91.64 THERMAL BURN | 1 0.01 91.65 THINKING ABNORMAL | 3 0.03 91.68 THIRST | 4 0.04 91.72 THREATENED LABOUR | 1 0.01 91.73 THROAT CANCER | 1 0.01 91.74 THROAT IRRITATION | 7 0.07 91.81 THROAT TIGHTNESS | 8 0.08 91.89 THROMBOCYTHAEMIA | 1 0.01 91.90 THROMBOCYTOPENIA | 23 0.23 92.13 THROMBOCYTOPENIC PURPURA | 3 0.03 92.16 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 92.17 THROMBOSIS | 27 0.27 92.44 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 92.45 THYROGLOBULIN INCREASED | 1 0.01 92.46 THYROID CANCER | 1 0.01 92.47 THYROID DISORDER | 4 0.04 92.51 THYROID FUNCTION TEST ABNORMAL | 2 0.02 92.53 THYROID NEOPLASM | 5 0.05 92.58 THYROID NODULE REMOVAL | 1 0.01 92.59 THYROID OPERATION | 1 0.01 92.60 TIBIA FRACTURE | 2 0.02 92.62 TINNITUS | 6 0.06 92.68 TONGUE BITING | 2 0.02 92.70 TONGUE DISCOLOURATION | 1 0.01 92.71 TONGUE DISORDER | 1 0.01 92.72 TONGUE DRY | 1 0.01 92.73 TONGUE ERUPTION | 1 0.01 92.74 TONGUE PARALYSIS | 2 0.02 92.76 TONGUE ULCERATION | 1 0.01 92.77 TONSILLITIS | 1 0.01 92.78 TOOTH ABSCESS | 2 0.02 92.80 TOOTH DISORDER | 4 0.04 92.84 TOOTH EROSION | 1 0.01 92.85 TOOTH EXTRACTION | 11 0.11 92.96 TOOTH FRACTURE | 1 0.01 92.97 TOOTH INFECTION | 2 0.02 92.99 TOOTH INJURY | 1 0.01 93.00 TOOTH LOSS | 6 0.06 93.06 TOOTH RESORPTION | 1 0.01 93.07 TOOTHACHE | 3 0.03 93.10 TORSADE DE POINTES | 3 0.03 93.13 TORTICOLLIS | 1 0.01 93.14 TOXIC ANTERIOR SEGMENT SYNDROME | 3 0.03 93.17 TOXIC EPIDERMAL NECROLYSIS | 2 0.02 93.19 TOXIC SKIN ERUPTION | 2 0.02 93.21 TOXOPLASMOSIS | 1 0.01 93.22 TRANSAMINASES INCREASED | 7 0.07 93.29 TRANSFUSION REACTION | 1 0.01 93.30 TRANSIENT ISCHAEMIC ATTACK | 14 0.14 93.44 TRANSMISSION OF DRUG VIA SEMEN | 1 0.01 93.45 TRANSPLANT FAILURE | 1 0.01 93.46 TRAUMATIC BRAIN INJURY | 1 0.01 93.47 TRAUMATIC HAEMATOMA | 1 0.01 93.48 TREATMENT FAILURE | 1 0.01 93.49 TREATMENT NONCOMPLIANCE | 5 0.05 93.54 TREMOR | 28 0.28 93.82 TRICUSPID VALVE INCOMPETENCE | 1 0.01 93.83 TRIGEMINAL NEURALGIA | 2 0.02 93.85 TRIGGER FINGER | 6 0.06 93.91 TRISMUS | 1 0.01 93.92 TUBAL LIGATION | 1 0.01 93.93 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM | 1 0.01 93.94 TUBERCULOSIS | 1 0.01 93.95 TUBERCULOSIS OF EYE | 1 0.01 93.96 TUBULOINTERSTITIAL NEPHRITIS | 2 0.02 93.98 TUMOUR LYSIS SYNDROME | 2 0.02 94.00 TUMOUR MARKER INCREASED | 2 0.02 94.02 TUMOUR NECROSIS | 1 0.01 94.03 TYPE 1 DIABETES MELLITUS | 2 0.02 94.05 TYPE 2 DIABETES MELLITUS | 5 0.05 94.10 TYPE III IMMUNE COMPLEX MEDIATED REAC.. | 1 0.01 94.11 ULCER | 3 0.03 94.14 ULCER HAEMORRHAGE | 1 0.01 94.15 ULTRASOUND SCAN | 1 0.01 94.16 UMBILICAL HERNIA | 1 0.01 94.17 UNDERWEIGHT | 1 0.01 94.18 UNEVALUABLE EVENT | 15 0.15 94.33 UNRESPONSIVE TO STIMULI | 4 0.04 94.37 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 94.39 UPPER LIMB DEFORMITY | 1 0.01 94.40 UPPER LIMB FRACTURE | 4 0.04 94.44 UPPER RESPIRATORY TRACT INFECTION | 2 0.02 94.46 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 94.47 URAEMIC ENCEPHALOPATHY | 1 0.01 94.48 URETERAL DISORDER | 1 0.01 94.49 URETERIC ANASTOMOSIS COMPLICATION | 1 0.01 94.50 URETERIC OBSTRUCTION | 1 0.01 94.51 URETERIC REPAIR | 1 0.01 94.52 URETHRITIS | 1 0.01 94.53 URGE INCONTINENCE | 1 0.01 94.54 URINARY HESITATION | 2 0.02 94.56 URINARY INCONTINENCE | 6 0.06 94.62 URINARY RETENTION | 3 0.03 94.65 URINARY TRACT INFECTION | 25 0.25 94.90 URINARY TRACT INFECTION ENTEROCOCCAL | 1 0.01 94.91 URINARY TRACT INFECTION PSEUDOMONAL | 1 0.01 94.92 URINE ANALYSIS ABNORMAL | 1 0.01 94.93 URINE FLOW DECREASED | 2 0.02 94.95 URINE OUTPUT DECREASED | 5 0.05 95.00 URINE OUTPUT INCREASED | 2 0.02 95.02 URTICARIA | 20 0.20 95.22 UTERINE CANCER | 2 0.02 95.24 UTERINE HAEMORRHAGE | 2 0.02 95.26 UTERINE LEIOMYOMA | 2 0.02 95.28 UTERINE PERFORATION | 1 0.01 95.29 UTERINE POLYP | 2 0.02 95.31 UTERINE SYNECHIAE | 1 0.01 95.32 VAGINAL CANCER | 1 0.01 95.33 VAGINAL DISCHARGE | 2 0.02 95.35 VAGINAL HAEMORRHAGE | 10 0.10 95.45 VAGINAL INFECTION | 4 0.04 95.49 VAGINAL PAIN | 2 0.02 95.51 VAGINAL STRICTURE | 1 0.01 95.52 VARICES OESOPHAGEAL | 1 0.01 95.53 VARICOSE VEIN | 1 0.01 95.54 VASCULAR GRAFT | 1 0.01 95.55 VASCULAR OPERATION | 1 0.01 95.56 VASCULAR PSEUDOANEURYSM | 1 0.01 95.57 VASCULAR RUPTURE | 1 0.01 95.58 VASCULITIS | 5 0.05 95.63 VASODILATION PROCEDURE | 1 0.01 95.64 VEIN PAIN | 1 0.01 95.65 VENA CAVA THROMBOSIS | 1 0.01 95.66 VENOOCCLUSIVE LIVER DISEASE | 2 0.02 95.68 VENOUS ANEURYSM | 1 0.01 95.69 VENOUS HAEMORRHAGE | 1 0.01 95.70 VENOUS OCCLUSION | 1 0.01 95.71 VENOUS THROMBOSIS LIMB | 2 0.02 95.73 VENTRICULAR ARRHYTHMIA | 2 0.02 95.75 VENTRICULAR DYSFUNCTION | 1 0.01 95.76 VENTRICULAR EXTRASYSTOLES | 3 0.03 95.79 VENTRICULAR FLUTTER | 1 0.01 95.80 VENTRICULAR HYPERTROPHY | 1 0.01 95.81 VENTRICULAR SEPTAL DEFECT | 8 0.08 95.89 VENTRICULAR TACHYCARDIA | 4 0.04 95.93 VERTEBRAL INJURY | 2 0.02 95.95 VERTEBROPLASTY | 1 0.01 95.96 VERTIGO | 9 0.09 96.05 VIOLENCE-RELATED SYMPTOM | 5 0.05 96.10 VIRAL INFECTION | 6 0.06 96.16 VIRAL LOAD INCREASED | 1 0.01 96.17 VISION BLURRED | 19 0.19 96.36 VISUAL ACUITY REDUCED | 17 0.17 96.53 VISUAL BRIGHTNESS | 1 0.01 96.54 VISUAL DISTURBANCE | 20 0.20 96.74 VITAMIN B12 INCREASED | 1 0.01 96.75 VITH NERVE DISORDER | 1 0.01 96.76 VITH NERVE PARALYSIS | 3 0.03 96.79 VITREOUS DETACHMENT | 1 0.01 96.80 VITREOUS FLOATERS | 2 0.02 96.82 VITREOUS HAEMORRHAGE | 1 0.01 96.83 VOLVULUS | 3 0.03 96.86 VOMITING | 87 0.87 97.73 VULVOVAGINAL BURNING SENSATION | 1 0.01 97.74 VULVOVAGINAL DISCOMFORT | 2 0.02 97.76 VULVOVAGINAL DRYNESS | 4 0.04 97.80 WALKING AID USER | 2 0.02 97.82 WALKING DISABILITY | 1 0.01 97.83 WEIGHT DECREASED | 66 0.66 98.49 WEIGHT FLUCTUATION | 4 0.04 98.53 WEIGHT GAIN POOR | 1 0.01 98.54 WEIGHT INCREASED | 77 0.77 99.31 WEIGHT LOSS POOR | 4 0.04 99.35 WHEEZING | 2 0.02 99.37 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.38 WHITE BLOOD CELL COUNT DECREASED | 20 0.20 99.58 WHITE BLOOD CELL COUNT INCREASED | 3 0.03 99.61 WITHDRAWAL SYNDROME | 3 0.03 99.64 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 99.65 WOUND | 3 0.03 99.68 WOUND DEBRIDEMENT | 5 0.05 99.73 WOUND DEHISCENCE | 1 0.01 99.74 WOUND DRAINAGE | 2 0.02 99.76 WOUND HAEMORRHAGE | 1 0.01 99.77 WOUND INFECTION | 3 0.03 99.80 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.81 WOUND SECRETION | 1 0.01 99.82 WOUND TREATMENT | 1 0.01 99.83 WRIST FRACTURE | 2 0.02 99.85 WRONG DRUG ADMINISTERED | 2 0.02 99.87 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 9 0.09 99.96 X-RAY ABNORMAL | 1 0.01 99.97 XEROPHTHALMIA | 2 0.02 99.99 XEROSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015